top of page
DHA ARA Omega 3 palmitoylate oleoylate ether linked fatty acid Enriched Phosphatidylcholin

Vitrupath
The fermi surface for AI enabled deep value health information

the authorization code to access other pages and training documents = vitrupath

00:00 / 03:38

Somewhat Comprehensive Overview New and Original 

Most Recent 

​​​​

Data Derivatization 

A most pivotal observation in this derivatization is that the primary foundational factors in detrimental aspects of advancing age, including graying of hair, metabolic changes, potential for deterioration of neurological function, deterioration of the anion gap, deteriorating musculature, and conditions that emerge to deteriorate neurological tissue during detrimental sudden events or advancing pathology are presented.  

Communicating the following paragraph to one's provider of care, health services provider, clinician, practician, or nutritional advisor can be important to stability, health status and expanse of being, while each of these roles optimally should use these or develop their own homologous assuring capabilities of health status using clinical data systems powered with Agentic Artificial Intelligence.

Simplistically, Enlyte, EnlyteRX, Niagen or potentiators of NAD+, NAD+ to assist bioavailability of NAD+, Molecular hydrogen such as in Dr Mercola's H2 and potentially Lecithin, leaky gut therapy (either of the factors Taurisola, 33 DBM, quercetin, resveratrol and grape pomace extract with maltodextrin, polyphenols such as resveratrol and catechins and quercetin and quercetin-3-O-glucoside, olive oil, balsamic Vinegar, Grapeseed Oil, periodic laxative, prebiotic, probiotic, postbiotic, macrobiotic foods, living foods, periodic antibiotic, water, fasting, or a broad spectrum or phenotyped antibiotic during an emergent condition). EMF protective clothing, covering stickers, and devices also enhance these sustaining capabilities.  Intravenous supply of NAD+, NAD+ potentiators, leaky gut intervention, phospholipids such as choline and phosphatidylcholine, and other factors exhibited in this document where possible, including SARM1 inhibitors, during emergent care, can be powerful intervention capabilities.

 

1, Methylene cysteine, (clinically Hcy) at or above 6  μM/L. Enlyte or EnlyteRx as a foundational therapy, while Folate with B12 methylcobalamin, S methylmethionine sulfonium, Betaine or trimethylglycine, B6 or a complete B Vitamin.  Most of the statistical data considers methylene cysteine to be clinically detrimentally affective at 15  μM/L, although methylene cysteine begins to increase pathology and risk when it reaches 7  μM/L.  

2, S adenosyl methylene cysteine (Clinically SAH) at or above 0.012  μM/L. Foundational therapies include Dimethyl sulfoxide, NAD+ potentiators such as Niagen, and actual NAD+. 

3, deterioration of the NAD+/NADH ratio (optimally in mammalian tissue between 1 and 10 or optimally at 3) and (optimally in cytoplasm between 60 and 700, or optimally at 700).  Therapies include NAD+ potentiators and NAD+.  

4, Overactive NADase activity Particularly SARM1, PARP(including PARP1), CD38, CD157, and potentially Sirtuins including SIRT1.  SARM! activation has emerged as a strongly linked causal factor to deterioration of neurological center during detrimental physiological conditions, Alzheimer's, Parkinson's, ALS, Multiple Sclerosis, other neurological degenerative disease, dimension, Glioma, GBM Oncology, and other conditions including persistent TBI and impairment of the major neurological context resultant of inadequate nutrients, ischemia or Hypoxia. SARM1 is repressed incompletely by Isoquinolones, clinically by an increased NAD+/NMN ratio(increasing NAD+ or decreasing NMN nicotinamide mononucleotide), and by emerging inhibitors of the SARM1 armadillo domain which are become available in will more than likely vastly eradicate Multiple Sclerosis, ALS, Parkinson's, Huntington's, Alzheimer's Dementia and Neurological degenerative conditions, or at least becoming the clinically incipient therapy in eradicating these conditions.  Each of these factors are also potent producers of S adenosyl methylene cysteine. NAD+ to NMN ratio indicates how much NAD+ is available to displace NMN from the SARM1 armadillo domain to cause repression of SARM1 ability to catabolize NAD+ to cADRP and ADPR which then cause distress in axons, neurons and astrocytes to promote apoptosis or neuronal deterioration. Repressing SARM1 and assuring NAD+ availability can redirect NAD+ for PARP1 enablement of DNA repair and enable PARP1 to be displaced by DNA repair capabilities that result in optimal homologous DNA repair. 

5, Commandeering of glycolysis and subsequent dysregulation of glycolysis known as aerobic glycolysis. This condition and can result in repression of glycolysis by P53 and repression of glycolysis by NAD+ unavailability which occur particularly when the enzyme PEMT1 S is inhibited, the enzyme FOXO3 is repressed to prevent its promoting repression of mTorc1 and promoting of mTorc2 which participates in associating the endoplasmic reticulum membrane with the mitochondrial membrane known as the mitochondrial associated membrane which is the only known habitat for enzymes PEMT2 L and PEMT3 L.  PEMT1 S emerges as conception or before to power development of anatomy while PEMT2 L and PEMT3 L emerge in the mitochondrial associated membrane near conclusion of gestation to regulate the growth promoted by endoplasmic reticulum membrane PEMT1 S. FOXO factors strongly regulate pace of use of stemness reserves while PEMT2 L and PEMT3 L strongly increase the pause that occurs between mitotic cycles even in diseases that are comprised of changes to mitotic cycle velocity. The role of PEMT is controversial because it produces methylene cysteine like other methyl transferases, although PEMT produces methylene cysteine in a nonharmful way and its production of s adenosyl methylene cysteine supplies support for the cycling of a primordial protein and amino acid synthesis pathway which in physiology is methylene cysteine acquisition of a methyl group to become methionine, methionine acquisition of ATP and carbocation rearrangement to become s adenosyl methionine with an ionized Sulfur atom, metabolism of s adenosyl methionine to s adenosyl methylene cysteine, s adenosyl methylene cysteine becoming either s adenosyl methionine or methylene cysteine, while primordial conditions exhibit methylene cysteine and mercaptopropanal as potentiators of methionine, and while UAG codon for methionine is encoded in 99.5 percent or more of proteins and while even when UAG is not encoded in a protein methionine is pervasively inserted anyway as the first sequence encoding in tRNA translation activity by ribosomal molecular machines. PEMT packs CH3 which as at least one hydrogen that is hydrogen anion, into membranes by packing CH3 into the 3 open loci of the ethanolamine lead group of newly produced, nonglycosylated or unglycosylated, resolution face fatty acid(docosahexaenoic, extended length arachidonic, oleoylic, palmitoylic, and Omega-3) dense phosphatidylcholine. Three sequential methylations produced phosphatidylmonomethylethanolamine, phosphatidyl2methylethanolamine and then de novo synthesis of choline as phosphatidylcholine.  The catalyzes produces choline which is a caustic quaternary ammonium factor that performs with these other molecules to promotes separation of the biotic phase from the abiotic phase, supports sequestration of useful factors from the abiotic phase for import into the biotic phase, derivatization of useful factors within the biotic phases, deterioration of oncology promoting molecules at their structural basis, promoting of early developmental plasticity by enabling serine protease activity, enabling glycolysis to occur without regulation of P53 by promoting genomic stability, and causes expression of oxytocin which enables the foundational aspects of social, emotional, Human and species level connection that is the neurological foundation for group, social, and civilization level behavior.  Methyl groups are optimally, resultant of PEMT, exhibited in membranes at a 1 to 1 basis with growth factors or hormones as regulators of how these factors promote growth through mTorc1 at lysosomes. 

6, These factors suggest that NOPE1, NOPE2, Lecithin, synthesis of S adenosylmethionine, and fatty acids Omega 3,  omega 6,  and other emerging versions, are useful in sustaining physiology. Rapamycin which inhibits mTor1 and does not affect mTorc2 may also be useful since studies have presented their usefulness in enhancing expanse of being.

7, Repression of glycolysis potentiates commandeering of glycolysis to direct pyruvate and NADH toward lactate and NAD+ to power nonresolution catabolism of NAD+ and strong gradients of NAD+ produced by catabolism of NAD+.  This syndrome can deteriorate production of nucleotides and NADPH through commandeering of glycolytic resources. Resultantly, Pyruvate can become unable to be transported by the mitochondrial pyruvate carrier into the mitochondria, a syndrome known as MPOS can emerge to prevent import of proteins in the mitochondria known as MPOS, Krebs cycle can be resultantly deprived of substrate, the electron transport pathway can be deprived of substrate, the electron transport pathway can become unable to be initiated,  Thioretinaco ozone can become unable to be exhibited as the site of oxidative phosphorylation, complex I of the electron transport pathway can become unable to supply the Thioretinaco Ozonide with an hydrogen anion multiplicity( in this instance an electron) which would cause the Thioretinaco Ozonide complex to become the ATP synthase complex or Complex V of the Electron Transport pathway, Complex V or ATP Synthase complex can then become deprived of substrate provided as hydrogen anion multiplicity (in this instance with quantum ambivalence that allows fragmented transfer of eV and Fluorescence) from Complex IV of the electron transport pathway, ATP Synthase ability to reduce Oxygen with its supplied Hydrogen anion multiplicity can then be prevented which then prevents ATP Synthase from performing Oxidative phosphorylation which involves packing of hydrogen anion multiplicity into oxygen to produce Oxonium that is nestled between the phosphate groups of ATP.  Sustained activity by ATP synthase assists in reducing reactive oxygen and reactive molecular species, stabilized the mitochondrial permeability pore, and prevents foundational dysbiosis and disease. The 700/1 ration of NAD+/NADH in the cytoplasm is important because these pathways use it change oxidative/reductive redo conditions that enable commandeering of Hydrogen anion from tissues, membranes and cytoplasm to load hydrogen anion's Multiplicities from the NAD+/NADH gap and from the systemic Anion Gap onto NAD+ to produce NADH and FADH2.   NADH and FADH2 are used by the Electron Transport Pathway for energy and substrate. These analysis have confirmed in the research that hydrogen is a component in every atom and helium/hydrogen comprise 97 percent or more of the Universe, such that interactions among ions of atoms might be most accurately described as interactions among nuances of hydrogen, enabling a perspective of the anion gap in physiology as being quantumly comprised of interaction among hydrogen, hydrogen anions, or in physiology being comprised of interactions among the NAD+/NADH Anion Gap.  Canonical observational insight links NAD+ depletion with oncology and other disease, while commandeering of glycolysis is also canonically linked with disease and oncology.  Oxidative disease, compared to glycolytic disease, is a misnomer because it does not simply reference oxidative phosphorylation but is a reference to oxidative stress, reactive oxygen species and other reactive molecular species which can reprogram emergence from stemness and reprogram ability to completely different from stemness to completed tissue specific differentiation pathways.  The literature suggests that the Thioretinaco Ozonide complex is exhibited and becomes the active site of oxidative phosphorylation but does not actually initiate either, although Thioretinaco Ozonide is involved in exhibition of oxidative phosphorylation and although it links the electron transport pathway to oxidative phosphorylation. 

8, Molecular Hydrogen, H2, such as the supplement Dr Mercola's H2 emerges as a capability to support hydrogen availability.  


9, The mitochondrial ATP synthesis complex is in intermediary between complexes II and III, according to some of the literature.  Details of the ATP synthase activity is also presented in another manner.  Ozone as O3, molecular oxygen as O2 and ATP integrate into the disulfonium derived thioretinaco ozonide TR2CoO3 which is a component of the F1 mitochondrial membrane oxidative phosphorylation complex F1. Tr2CoO3O2 complexing with NAD+ and Phosphate H2PO4- produces the active site for oxidative phosphorylation which is TR2CoO3O2NAD+H2PO4-. Catalysis is comprised of oxidative phosphorylation introduction of an electron to reduce the pyridinium nitrogen of the NAD+ nicotinamide, which results in polymerization of phosphate and adenosine diphosphate, thereby constituting nicotinamide riboside and thereby constituting ATP/thioretinaco ozonide oxygen Tr2CoO3O2ATP. Dynamic activity occurs when the second electron is introduced to reduce oxygen to hydroperoxide radical which causes ATP to be released and potentiating pumps that translate electrons into ATP.  Thus, ATP harbors virtualized Hydrogen anion which has become a field, a wave function, particle function, fluorescence and superposition which the research suggest do not have to be presented individually and can be exhibited all at once.   F1F0 complexes provide protons and electron transport pathway complexes provide electrons, which interact with dehydroascorbate to produce iterative reducing of the oxygen molecule that is linked to thioretinaco ozonide. The chiral attachment and release of ATP from the ATP synthetase of the F1 complex can then occur.  Disease typically involves impaired ability of thioretinamide complexes to oxidize radicals and use the electrons to reduce the oxygen of thioretinaco ozonide complexes. Thioretinaco ozonide is also typically attached to ATP synthase of F1 complexes and thus enables synthesis of s adenosyl methionine using ATP and methionine. This is an important and inadequately presented metabolic context, the use of ATP to reduce methionine using s adenosyl methionine synthase.  Mitochondrial pore dysregulation and impaired mitochondrial function can deteriorate de novo synthesis of s adenosyl methionine while also potentiating increased levels of methionine.

 

10, A particular resource presents  (NHTR)2CblO3O2ATP as a therapeutic in which NHTR is N methylene cysteine thiolactone Retinamide.

 

11, Inhibition of PEMT, phosphatidylethanolamine methyltransferase, causes an increase in the CDP choline pathway to increase synthesis of phosphatidylcholine to replace the typical 30 percent of phosphatidylcholine produced as de novo choline in phosphatidylcholine that typically occurs from PEMT activity.  CDP choline pathway is initiated by choline kinase, has some production of each of the produces produced by the CDP ethanolamine pathway, competes with s adenosyl methionine synthase for ATP because choline kinase produces phosphocholine from ATP and free choline, recycles choline instead of producing de novo choline, is a major interventional capability of allergic/anaphylactic/xenobiotic/toxic intervention, is increased almost all if not all disease, produces phosphocholine used by vast aspects of disease and disease causing microbes for energy, is increased by AP1 and SP1, causes low level activation of the complements immunological system, causes activation of platelets, activates GPCR receptors, produces S1P, enables activation of S1P receptors, over activates resiliency of tissue to programmed deterioration and is major therapeutic resistance pathway through activation of S1P lyase. Choline kinase can be beneficial in ephemeral duration to sustain physiology while potentiating disease with increasing nonephemeral duration. Choline Kinase inhibitors foundationally deteriorate pathways and factors used in all disease. Berberine represses SP1.  Curcumin represses AP1. Active hexose correlated compound represses choline kinase.   Pharmacological inhibitors for AP1, SP1 and choline kinase alpha have been development and should be available. Such inhibitors widely suppress disease, oncology, and other dysbiosis.  Choline kinase as another factor that effects metabolisms by depleting 

12, inhibition of choline kinase alpha, inhibition of AP1, and inhibition of SP! May be powerful capabilities in stabilizing physiology. 

13, Environmental particulate, aquatic particulate, atmospheric particulate, pollution, and toxic factors can decrease the percentage of atmosphere that is comprised by oxygen, decrease the availability of oxygen carried by systemic capabilities and can cause mimicking of hypoxia or low oxygen conditions by activating the Hypoxia Response Element which is typically near the Serum Response Elements and near other Response element kits.  These factors can cause hypoxia and near hypoxia, resulting in activation of the these response elements that change or repress programming at the foundational compartment level and promote overly resilient tissues that care linked disease of dysregulated proliferation, particular using HIF alpha. The AhR aryl hydrocarbon receptor is activated by toxic factors in environment, atmosphere and physiology, activating HIF Beta.  Each of these can change programming for foundational compartments to become overly resilient to conditions and thereby escape regulation of differentiation and escape regulation of proliferation.  

14, Clean environment, the removal of toxic factors from environment, avoiding use of toxic factors to clean the environment, use of air cleaners and purifiers, assurance of clean water, clean atmosphere, supply of clinical oxygen, detoxification therapies, and relevant factors emerge as supportive preventively and interventionally. 


Detailed Derivation

Methylene cysteine known as (clinically known as Hcy, homocysteine, (2S) 2 amino 4 sulfanylbutanoic acid, 2 AMINO 4 MERCAPTO BUTYRIC ACID, 
0LVT1QZ0BA, L 2 Amino 4 mercaptobutyric acid, 2 amino 4 mercapto Butyric acid, 2 amino 4 sulfanylbutanoate, 2 amino 4 mercapto Butanoic acid, (2S) 2 azaniumyl 4 sulfanylbutanoate, (2S) 2 azaniumyl 4 sulfanylbutanoate, 2 amino 4 mercaptobutyric acid, Butanoic acid, 2, amino 4 mercapto , 2 Amino 4 Mercaptobutyric Acid, 2 Amino 4 Sulfanylbutanoic Acid, (s) 2 amino 4 mercaptobutanoic acid, (S) 2 Amino 4 mercaptobutyric acid, Butyric acid, 2 amino 4 mercapto  L , 2 Amino 4 mercaptobutyric acid (VAN), Butanoic acid, 2 amino 4 mercapto , Butanoic acid, 2 amino 4 mercapto , (S) 2 amino 4 mercapto Butanoate, 2 amino 4 mercapto DL Butyrate, (S) 2 amino 4 mercapto Butanoate, L 2 amino 4 mercapto Butyric acid, (s) 2 amino 4 mercaptobutanoicacid, 2 amino 4 mercapto DL Butyric acid, DL 2 amino 4 mercapto Butyric acid, (S) 2 amino 4 mercapto Butanoic acid) 


Methylene cysteine and relevant metabolites relegated to these levels and other relevant insight

This information clearly and strongly presents that the cause of aging, and detrimental aspects of again, in mammals and Homo Sapiens can be prevented and alleviated by preventing increases in methylene cysteine, particularly keeping methylene cysteine lower than 6  μM/L, assuring adequate levels of NAD+, preventing attrition of NAD+ by NADases, and maintaining tissue levels of NAD+/NADH ration between 1/1 and 1/10, possibly near about 3/10, maintaining cytoplasmic NAD+/NADH ratio between 60/1 and 700/1, optimally near 700/1, maintaining s adenosyl methylene cysteine levels lower than 0.012  μM/L, assuring function of PEMT, assuring exhibition of the mitochondrial associated membrane which is the only known habitat for PEMT2 L and PEMT3 L which are regulators of endoplasmic reticulum PEMT1 S.  PEMT1 S emerges near gestation and power growth and metabolism while PEMT2 L and PEMT3 L emerge near conclusion of gestation to regulate the powered growth enabled by PEMT1 S, while PEMT2 L and PEMT 3L are known to causes increase in the pause between mitotic cycles, while PEMT2 L alone, in disease involving mitotic regulation is known to increase the duration of pause between mitotic cycles by between 100 and 200 percent.  It is also known FOXO factors repress depletion of stem reserves and FOXO1 represses mTorc1 while enabling expression of mTorc2 participates in causing association of the mitochondrial membrane with endoplasmic reticulum membrane to constitute the mitochondrial associated membrane. Importantly, mitosis can involve 1 of each mitotic output to become recruited into stemness, particularly with particular genetic expression that causes the original DNA sequences that were used to initiate mitosis being selected for recruitment into stemness reserve.  Together with perfect Genetic Repair using CRISPR enabled by transduction domains for 100 percent permeability of all available tissue and PROTAC ability to specifically find and remove impaired proteins, these constitute a now capable ability to prevent what is known of as aging.  

Methylene cysteine level< 6 µm/L. s adenosyl methylene cysteine < 0.012 µm/L/.  NAD+/NADH about 1/1 to 1/10 while in cytoplasm about 700/1, but possibly as low as 60/1 circumstantially in compartments.  Therapeutic prevention of NADase activity to prevent catabolism of NAD+. Support and supply of glycolysis supply of substrate to Krebs Cycle, Pyruvate transport to Krebs cycle, Krebs cycle supply of substrate to the electron transport pathway, thioretinaco ozonide complex initiation of electron transport pathway in the cristate of the inner mitochondrial membrane, electron transport pathway access NADH and FADH2, Complex I supply of hydrogen anion quantum multiplicity to Thioretinaco ozonide complex for its metabolisms to the ATP synthase Complex/Complex V, Complex v/ATP Synthase obtain of hydrogen anion multiplicity from electron transport pathway to enable the packing of the boundless multiplicity of hydrogen anion into two oxygen atoms to produce oxonium that is packed between the phosphate groups of ATP.  

The information presented in this context explains how experimental conditions produced an inability to ascertain cognitive, observational, diagnostic, clinical, functional, and activity differences in early developmental and extremely advanced age small nonhuman mammals, which present opportunities to support indefinitely sustainable being in Homo Sapiens Sapiens.

Regulation of the mitochondrial permeability pore and its supply of ATP to phosphorylation cascades. Regulation choline kinase alpha potential for overexpression and overuse of ATP.  Assure that ATP is available for synthesis of s adenosyl methionine. Assure that s adenosyl methylene cysteine becomes s adenosyl methionine or is metabolized to methylene cysteine for attachment of a methyl group to produce methionine or is depleted through the transsulfuration pathway of cystathionine beta synthase and cystathionine gamma lyase.   

Assuring that early biome exhibition of methylene cysteine Hcy, mercaptopropanal and methionine as potentially the first amino acids the encoding of methionine in more than 99 percent of proteins and the insertion of methionine by tRNA at ribosome molecular machines as the first amino acid in protein synthesis even if methionine is not encoded by DNA for a protein.  

Assuring that ATP is available for attachment to methionine which causes a carbocation rearrangement in which the hydrogen multiplicity of its oxonium is redistributed throughout the s adenosyl methionine molecule to cause an ionization of the sulfur to S+.  

Assurance that CH3 and its hydrogen anion component within s adenosyl methionine is available for removal from s adenosyl methionine by PEMT, packing into membranes by the enzyme PEMT1 S beginning near conception or before and then PEMT2 L and PEMT3 L beginning near conclusion of gestation both in regulation of the developmental and to massively decrease mitotic velocity potentiated by PEMT1 S.  

Regulating mTorc1 in factor of Mtorc2 because mTorc2 because mTorc2 promotes the exhibition of the mitochondrial associated membrane shared by the endoplasmic reticulum and the mitochondria which is the only known habitat for PEMT2 L and PEMT 3L, while PEMT1 is exhibited in the membrane of the endoplasmic reticulum.  

Assuring Cx43 and AQP4 is available for transport of NAD+ and modulated to prevent gap junction exchange of antimetabolites and elements disease used in disease proliferation and expansion, although the same regulation must be used to regulate detriment vesicles exported from the cytoplasm to other local and distal tissues.  

Regulation and management of primary inhibitors of PEMT such as CRP protein, tmao protein, AP1 protein and SP1 protein which interact to produce a primary escape mechanisms from replicative senescence, Methylglyoxal, IDO, iNOS/NOS2, Oxalate, and methylene cysteine known as Hcy.   

Requiring the implementation of these capabilities in all instances of care. 
Inpatient admittance when methylene cysteine is at or above 15 µmol/L, regardless of if there are symptoms or not. 
Inpatient admittance if methylene cysteine Hcy is at 10 µmol/L or higher along with symptoms.  
Outpatient care if methylene cysteine is 10 µmol/L or higher without symptoms.  
Outpatient care if methylene cysteine is above 6 µmol/L with symptoms.  
Office Visit, Primary or other modalities of care if methylene cysteine is µmol/L is above 6 µmol/L
Therapies of methylene cysteine should have a priority of creating 2 weeks of methylene cysteine lower than 6 µmol/L with a goal of reaching 3.7 µmol/L, while managing methylene cysteine after two weeks of lower than 6 µmol/L is reached. 
Practice management analytics and Agentic AI should be used to refine practice parameters used in each practice instance using improvement statistics and extended duration follow up outcomes because the capabilities of care are so expansive and the physiologically causal factor can be metabolic, behavioral and environmental including activation of the HRE hypoxia response element, genetic status, environmental toxins which activate Aryl Hydrocarbon receptor and HIF2 alpha activation by AHr, response to external factors by PEMT, Choline Kinase Alpha, and methyltransferase other than PEMT. 
Implementation of factors that are known to alleviate the effects of methylene cysteine because methylene cysteine might be increase instantaneously or circumstantially as well persistently or otherwise. 
Agrin hypodermic insertion into ECM matrix to cause complete regeneration of central most substantial circulatory function tissue complex. 
Repression of methylene cysteine to < 6 µmol/L toward 3.7 µmol/L which are causally linked to all factors occurring detrimentally with increase age and differences in prognosis, health status, susceptibility to disease and level of disease.
Modulate NAD+ attrition pathways, NAD+ production pathways, NAD+/NADH ratio, NMN/NADH ratio and NAD+/ADPR and NAD+/cADPR ratios, which are causally linked to all factors occurring detrimentally with increase age and differences in prognosis, health status, susceptibility to disease and level of disease.
Requiring tmao protein to be proactively repressed and repressed in every care intervention because it is the among the most causal risk elements to adverse health outcomes, sudden adverse events, sudden adverse vascular events, perioperative complications, cardiovascular risk, and other adverse outcomes.
Repression of USAG1 and BMP7 to cause complete regeneration of all dental structure. 
Use of an environmental and individual group of EMF protection capabilities, modalities, tools and protocols.
Modulation of USAG1 and BMP7 to cause complete regeneration of the renal tissues and renal complexes.
Use of FoxN1 to cause complete regeneration of the thymus complex and tissues. 
Use of PROTAC to specifically remove particular disease factors and proteins
Use of CRISPR Genetic Editing to resolve any genetic anomalies which have emerged to cause disease, enable susceptibility to disease.
Use of CRISPR Genetic Editing to specifically genetically deteriorate or impede genetic expression by microbes with a formulation for every microbe known to cause disease.
Circumstantial modulation of SARM1 Armadillo Domain affect functional tissue, NMN/NAD+ ratio, NAD+/ADPR ratio, ADP/cADPR ratio, GDNF, Cx43, AQP4, MCP1, MCP2 and MCP3, along with L arginine availability modulation, emerge as dual a strong factors in therapeutically preventing and repressing conditions such MS, Parkinson's, AZ, and ALS conditions as well as the preventing and repression dysregulated control of proliferation of tissue in the same area of anatomy relevant to these conditions.
Resolving access to housing, clean water, clean restrooms, care coverage, care which considers that foundational causal factors to disease, nutritional stability, social stability, economic stability, safety, cognitive care, other social welfare requirements and other Human welfare requirements.
The factors presented in this context might be reasonable considered as including factors that might be the most causally relevant in exhibition, persistence and advancement of massive aspects of disease diminished behavior, advancement of disease and potential for detrimental prognosis.

Circumstantial modulation of NADases PARP1 or other PARP, CD38, CD157, Sirt1, and SARM1, although there can be other NADases in this context, because these cause attrition of NAD+ and diminished the effectiveness of NAD+ synthesis, recycling and supplementation in sustaining the  between 1 and 10 or 3 ratio of NAD+/NADH in tissue, and sustaining the between 60 and 700 or 700 ratio of NAD+/NADH in areas of the cytoplasm, each of which are important because these provide gradients that power the capture of the interstellar/terrestrial/biome/physiological hydrogen anion lake into NAD+ to produce NADH.  Hydrogen anion in its boundless nonquantized multiplicity and integrated into helium capture energy and redirect resources into producing celestial entities including stars that are similar to or cooler than the Sun, while hydrogen is the foundational atom including in every atom, hydrogen in its different status captures particles obtaining mass from the Higgs field as they assemble themselves, Hydrogen emerges from uncoordinated movement of electrons and protons which becomes coordinated in an orbital arrangement known as the hydrogen atom, while neutrons emerge slightly differently but are integrated to produce other atoms, such that hydrogen is a group of particles given mass by the Higgs fields to produce uncoordinated electrons and protons which then become coordinated into an orbital relationship to produce Hydrogen.  Hydrogen might be regarded as an orbiting relationship between an electron and proton which involves the electron presuming more prominently its particle multiplicity compared to its energy, wave, superposition multiplicities, although these other multiplicities are maintained and can even independently interact with as in quantum computing dynamics.  

Hydrogen anion involves capture of an electron into hydrogen resulting in an integrated high energy electron used to power important pathways such as glycolysis production of pyruvate and NADH, directing of pyruvate to the mitochondria and Krebs Cycle instead of other pathways including instead of potential directing of NADH and Pyruvate toward NAD+ and Lactate anion to supply substrate to dysregulated PARP signaling,  the Electron Transport Pathway, thioretinaco ozonide complex metabolic transition to become the ATP synthase complex or Complex V of the Electron Transport Pathway, fragmented aspects of hydrogen anion which are packed into Oxygen as oxonium between the phosphate groups of ATP in catalysis known as Oxidative Phosphorylation performed by ATP Synthase (complex 5 of the Electron Transport Pathway), and culminating in regulated dispensing of ATP and stabilization of the mitochondrial permeability pore. Important to these is the import of pyruvate into the mitochondria to enter the Krebs Cycle which becomes disrupted by redirecting of pyruvate and mPOS syndrome which prevents import of proteins into the mitochondria. The mitochondrial pyruvate carrier is involved in moving pyruvate into the mitochondria where the Krebs cycle uses pyruvate within the matrix of the inner mitochondrial membrane. 

Hydrogen is the most abundant atom in the universe, perhaps as much as a hydrogen/other atom ratio of 10/1 (according to some perspectives in some contexts of consideration which suggest that 90 percent all atoms are hydrogen, 92 percent of all atoms are hydrogen, 93 percent of all atoms are hydrogen, 75% of all atoms in the universe are hydrogen, 99 percent of all the atoms are hydrogen or hydrogen/helium conjugates and an estimated 61 percent of atoms in physiology are atoms, although, again, all atoms are purported to constitutively exhibit hydrogen) and this ratio is at least relevant to NAD+NADH ratios that power capture of hydrogen anion as a basis of sources of power that enable independent activity in coordination with, parallel to and sometimes in surmounting of the fundamental gradients of the biome.  This capture and redirection of power is a characteristic of Life. The anion gap or strong ions loosely regard the gap between NAD+ and NADH or the gap between other similar primary carriers of hydrogen anion(NADP+/NADPH, FAD/FADH2, or other) because this is an indicator of the availability of Hydrogen anion in both its integral molecular status and its boundless status as an excited integral hydrogen anion or as an ejected electron in its boundless multiplicity which more strongly is exhibited as 2 eV per Hydrogen anion( or fragmented variable eV as hydrogen anion absorbs between 0.75 and 4.0 eV of the electromagnetic spectrum and can donate or abdicate and receive such electromagnetic vectors in fragmented amounts), fluorescence, wave function, or Multiplicity. 

Most Recent Continued 

​​​​

Nutritional, environmental, mineral, biosynthetic, paramagnetic and quantum spin liquid, or other, modalities of hydrogen anion or electron multiplicity onboard or obtainment are known of, while particular research observes that nearest neighbor or first level exchange cannot exceed the velocity of light, although transitive multiple order exchange escapes this limitation, such that the known interaction of quantum spin liquids to reach to universes level exchange networks confirm experiments that present the ability to produce unobserved outcomes and then change those outcomes in subsequent instances of time by introducing and modulating new relationships with the multiple factors participating in the incipient observation. The information in the literature does not seem to be sure if this a fluid or spatial dynamic and is not sure if this results from hydrogen's encompassing multiplicities or if these dynamics are the result of the outer energy levels of all atoms being an open system which shares spatial and quantum aspects of the Universe.  One fact seems to be certain, the multiplicities of all particles in the Universe such as wave, particle, energy, fluorescent, superposition and  including other which are not yet completely ascertained and understood, involve paradoxes in which the material comprising an electron to permeate the nucleus of an atom, multiplicities that do not require impeding interactions, whereas all throughout the universe the exhibition of material aspects of the Universes seem inconsequential which require such impeding interaction largely benefit the exhibition of life and largely benefit cognitive aspects of intelligent being.  Hardly any celestial interaction between material aspects of the universes are beneficial to the entities involved, except that these are beneficial to life. 

Exchange of photons is essential in observation of material factors and material of the Universe which result in collapse of quantum material and electrons in particular into their particle multiplicity. Such interactions are coupled with transitive interactions occurring at universes levels that are quantumly entangled, which are presented as occurring as rapidly as 30,000 times the velocity of light, which through transitive interactions escape axioms or postulations which relegate nearest neighbor interactions among quantumly entangled interactions to the velocity of light, including interactions into antecedent eras and into eras which are to come and even into eras that have already emerged in aspects of the future. There is a possibility that Life, increasingly in expansiveness of all Universes, interactively into antecedent instances of time and interactively into eras which are to come, including interaction with eras of immediacy, enable the inanimate aspects of the universes, too, to Live. 

These irrefutably represent a favor afforded by the creative forces of the universe to life, extended into all antecedent eras, all future eras, eras immediacy, all aspects of the material universe and untranslated substrate of the Higgs field, which through hydrogen and its multiplicities and version, encompassing of all structure of the universes, and culminated in the anion gap where hydrogen anion, electrons ejected from hydrogen anion,  hydrogen otherwise and its electrons in it quantum multiplicities are shared as a foundational resource in the catalytic nuances that sustain Life.  Although the anion gap is clinical phenomenon used clinically to determine balance between particular anions, there is a very strong correlation that suggests that these anions interact with quantum multiplicities enabled or supported by NAD+/NADH and other Hydrogen anion carriers as these supportive factors exhibit exchange, release, capture, regeneration, and interactivity through space and otherwise which constitute fields and resources. These fields and resource seem to emerge as factors that other atoms, molecules, physiology and physiological conditions may share, use or benefit from. 

The anion gap used in clinical medicine is presented as being detrimentally effected by disrupted NADH/NAD+ ratio while numerous factors which disrupt PEMT, commandeer glycolysis, affect redox exchange of ions, require toxicity intervention, or which cause disrupted cysteine pathways, increase methylene cysteine, or otherwise confirm the observation in this compendium of research. www.ebmcosult.com presents information on the Anion Gap differential diagnoses.  The  literature presents a typical anion gap between 8 and 12, with -2 or +2 variance possible. The anion gap diagnostically indicate toxic effects of Acetaminophen, alcoholic ketoacidosis, diabetic ketoacidosis, exposure to ethylene glycol, iron, metformin, phenformin, methanol, salicylates including salicylic acid, paraldehyde, cyano molecules, lactic acid, isoniazid INH, or other syndromes and toxic factors or conditions that repress PEMT, increase methylene cysteine, increase choline kinase alpha, redirect ATP toward phosphorylation cascade, disrupt mitochondrial respiration and production of ATP, overuse methyl groups, prevent adequate availability of s adenosyl methionine for PEMT catalysis, or directly sequester electrons or sequester hydrogen anion from NAD+/NADH gap, FAD/FADH2 gap, NADP+/NADPH gap, or from any other redox capable oxidized/reduce paired ion versions, all of which can be counteracted.  Research also correlated each standard deviation in the circulatory fluid anion gap with a 120 percent increase in risk for all causes of the most detrimental of outcomes in highly interventional care contexts, correlates increased anion gap with all causes of the most detrimental of outcomes when very advanced renal conditions are exhibited, nonlinearly correlates anion gap with all causes of the most adverse of outcomes in mature phases of being.  Calculated anion gap without potassium is Na-(CL + HCO3), calculated anion gap with potassium K is (Na + K) – (Cl + HCO3+), and calculation for the delta gap which does not use potassium K is [Na – (Cl + HCO3)] – 12.  Typical anion gap is between 8 and 12 mEq/L or  between 8 and 12 ?M/L.  D lactic acid is an obscure substantial risk factor for the most detrimental of outcomes and is typically correlated to lower than typical anion gap observations.  However, D lactic acid is linked to inability to metabolize  D Lactate, L Lactate and L lactic acid, which are linked to methylglyoxal availability, and methyl glyoxyl, L Lactic Acid and D Lactic acid are each linked to repression of the enzyme PEMT.  

The slopes  of  metabolites which decrease from age 20 to age 60 and older are presented as - 0.040 for NAD+,  -0.016 for NAAD, - 0.025 for NADP+, having strong correlation with methylene cysteine.  The slope of other relevant metabolites between age 20 and age 60 are 0.023 for NAM, 0.028 for MeNAM, 0.017 for ADPR, 0.027 for NADPH.  

Methylene cysteine, hcy, is strongly correlated with increasing phase of being. Methylene cysteine 15 um/L, and thus above 6 um/L, is correlating with advancing age and risk of the most detrimental of outcomes, the attrition among cohorts caused be methylene cysteine and methylene cysteine hcy > 15 um/L and thus above 6 um/L is changed once 80 years of age is reached because attrition among these advanced age cohorts escapes lower methylene cysteine Hcy.

NADase PARP including PARP!, SARM1, CD38, CD157, SIRT including SIRT1, but potentially other NADases release ribose as ADPR, cADPR or other from NAD+, thus diminishing the strength of the NAD+/NADH specific anion gap, while also producing s adenosyl methylene cysteine.   At least two of these result in a strong gradient of glycolysis NADH and Pyruvate to NAD+ and Lactate which deprives Krebs cycle of substrate and potentially deprives mitochondria of pyruvate, deprives pentose phosphate pathway of substrate nucleotide synthesis and NADPH synthesis, while also increasingly relegating pyruvate and NADH away from other pathways of glycolytic supply, all occurring in a way that that directs NADH to NAD+ which is then catabolized by NADases.  PARP and SARM1, and potentially these other NADases, then produce methylene cysteine Hcy from NAD+ while at least PARP1 exhibits persistent signaling awaiting availability of nucleotides that are repressed in this context of pentose phosphate pathway repression while PARP1 continues to deplete catabolize and deplete NAD+ to produce a gradient upon which substrate for DNA repair is recruited. ribose is attached to local substrate through parylation which uses the ribose to create a gradient to recruit DNA deoxy ribonucleotides which exhibit ribose and use ribose to create a gradient to recruit RNA as ribonucleotides which exhibit ribose. 

SARM1 and PARP1, at least, among NADase promote a condition known as parthanatos in which already differentiated tissue experiences deterioration, stem reserves are caused to emerge from stemness but are prevented from complete repression of stemness and are complexed from complete obtainment of fully differentiated status. This is highly trained phenotype that is linked with disease because it diminishes the plasticity and versatility of tissues.

SARM1 activation by increased NMN compared to NAD+ levels, produces ADPR and cADPR which repress GDNF and causes neurons and axons to deteriorate under stress or impairment. MCP1, MCP2 and MCP3 recruit leukocytes and activate leukocytes which perform deterioration of neurological tissue incipiently but then are repressed or move to the perimeter of expanding areas of pathology in a dynamic enabled by Cx43 and AQP4 while these same similar contexts are exhibited in other disease, except deterioration becomes repressed and is replaced by expansion of the pathology at perimeter of pathology using Cx43 and AQP4 signaling.   MCP1 is presented as being required and SARM1 is emerging as an important factor along with Cx43 and AQP4 in particular disease, multiple sclerosis, ALS, Alzheimer's, Parkinson's, Huntington's, dementia, neurodegenerative, and other conditions, which now have numerous pathways available for being developed for repression, prevention and alleviation. 

Enlyte and EnlyteRX repress methylene cysteine.  

Inhibitors of PARP including PARP1, SARM1, CD38, CD157, potentially circumstantially also SIRT1 repress highly toxic increases of methylene cysteine Hcy.

S adenosyl methionine provides substrate for PEMT which increases methylene cysteine but also produces numerous beneficial factors compared to toxic metabolites produced by other factors such as some NADases.  

The literature observes that PEMT decreases levels of methylene cysteine Hcy through a mechanism not fully and plainly described, although PEMT creates methylene cysteine, Hcy, as S-adenosyl methylene cysteine as product of its catalytic activity.  PEMT use phosphatidylethanolamine and S-adenosylmethionine as substrate to produce de novo choline as phosphatidylcholine, S adenosyl methylene cysteine and H+. PEMT moves CH3 involved in carbocation rearrangement within s adenosyl methionine where the hydrogen multiplicity of ATP within the adenosyl group of s adenosylmethionine is removed, resulting in fractal both in the leaving group of s adenosyl methylene cysteine and fractal within the CH3 being transferred to the Nitrogen of the lead ethanolamine group of the receiving phosphatidylethanolamine. Phosphatidylmonomethylethanolamine by transferring a methyl group to phosphatidylethanolamine and producing S adenosyl methylene cysteine, followed by subsequent catalysis in the same pattern to produce phosphatidyl2methyletabolamine PDME, then producing phosphatidylcholine from PDME, resulting in de novo synthesis of choline within the newly synthesized phosphatidylcholine, preferentially using newly synthesized, unglycosylated or lightly glycosylated phosphatidylethanolamine, phosphatidylethanolamine with nonresolution fatty acids docosahexaenoic acid, arachidonic Acid, Palmitoylic Acid, Oleoylic Acid, and Omega-3 fatty acid.   

PEMT production of methylene cysteine, Hcy, is probably integrated into its beneficial products to provide or sustain availability of methylene cysteine for the methyltransferases which produce methionine and do not produce methylene cysteine such as methionine synthase, BHMT, BHMT2, THMT, although cystathionine beta synthase and cystathionine gamma lyase can produced beneficial substrates also otherwise. PEMT may be in interstitial capability between methyltransferase that do not produce methionine, methyltransferase which do produce methionine and methylene cysteine metabolizing enzymes such as cystathionine beta synthase and cystathionine gamma lyase which produce other beneficial metabolites.  

PEMT uses newly produced, lightly glycosylates or unglycosylated phosphatidylethanolamine, beneficial fatty acid, and carbocation rearrangement (methyl shift,  (H2e1p) shift, Hydrogen anion Shift) CH3 from S-adenosyl methionine.

PEMT Produces PMME, PDME and then de novo choline as phosphatidylcholine with beneficial fatty acids at SN1 and SN2 positions. Also produces methylene cysteine, Hcy, that is considered to be nonharmful, although it contributes to levels of methylene cysteine (Hcy).  Might be a reason for disparities in health status.  

PEMT enzyme Moves a methyl group, CH3 that has at least on Hydrogen with an extra electron known as Hydrogen anion (H2e1p), from S-adenosyl methionine in three sequential transfers to the open locations of the Nitrogen in the ethanolamine lead group of phosphatidylethanolamine. The first methyl group transfer produces PMME, the second methylene produces PDME and the third methylation causes ethanolamine to become choline to cause de novo synthesis of choline. Pemt prefers newly produced phosphatidylethanolamine with lightly glycosylated tails or unglycosylated tails.  Pemt selects or prefers including of resolution phase fatty acids including Docosahexaenoyl, extended length Arachidonoyl, Palmitoyl, Oleoyl, and Omega-3 species.  

Phosphatidylethanolamine derived from the CDP-ethanolamine pathway (which is homologous to the CDP-Choline pathway synthesis of phosphatidylcholine which using existing choline to produce phosphatidylcholine) and phosphatidylcholine derived from phosphatidylserine decarboxylase in the Inner Mitochondrial Membrane and in the Golgi Apparatus, participates with components of the CDP-ethanolamine pathway and Methylthioglycolic acid to deteriorate the structural basis of oncology cause molecules, cause expression of tissue plasminogen activator which is a super clot busting factor, cause separation of the abiotic phase from the biotic phase and sequesters useful factors from the abiotic phase for import into the biotic phase while also causing derivatization of factors into more useful biological factors.

PEMT production packs CH3 and CH3 cargo of hydrogen anion into membranes which can be mined such as lands cycle phosphodiesterase and phospholipase freeing of fatty acids, phosphatides and choline factors from membranes for eicosanoid availability to control nonresolution phase signaling followed by recomplexing these factors to shuffle the beneficial fatty acids focused upon by PEMT catalysis and produced nonspecifically by the CDP-choline pathway.  CH3 is optimally exhibited on a one to one basis with growth factors membranes, while CH3 attaches itself to the leading edges of expanding structural lattices to abate their expansion.  

Pemt1 S, is of shorter length compared to both PEMT2 L and PEMT3 L, such that PEMT2 L and PEMT3 L both have only 1 known habitat which is the mitochondrial associated membrane. Confirmingly, Activated FoxO1 inhibits mTorc1 either using Tsc2 or without requirement of Tsc2. FoxO1 activates Sestrin3 causing increases in Sestrin3, while increased Sestrin3 represses mTorc1 signaling, particularly in the presences of Tsc2, while the increased expression of Rictor also causes increase in mTorc2 activity in a manner that leads to Akt activation. However, when Tsc2 is not exhibited, FoxO1 increasing of Rictor results in increased mTorc2 assembly in a manner correlated to the decreased expression of mTorc1. Importantly, mTorc2 performs in promoting of and as a linking factor for the mitochondrial associated membrane between the endoplasmic reticulum and the mitochondria. The mitochondrial associated membrane is where Pemt2 L and Pemt3 L function, is where Pemt2 L and Pemt3 L emerge near conclusion of gestation to perform their catalysis, is where Pemt2 L and Pemt3 L regulate the activity of Pemt1 S. Pemt1 S is exhibited in the endoplasmic reticulum membrane and Pemt1 S emerges at conception or before conception.

THMT thetin(thetine) Methylene Cysteine methyltransferase use 2methyltetin or trimethylsulphonium and methylene cysteine to produce methylthioglycolic acid and methionine.   

BHMT uses methylene cysteine and Betaine or Trimethylglycine or n,n,n glycine betaine to produce methionine and dimethylglycine.  

BHMT2 uses methylene cysteine and s methylmethionine sulfonium to produce methionine and dimethylglycine. 

INMT uses primary or secondary amines or amide, including selenium, or sulfur or telluride or other along with S adenosyl methylene cysteine to bidirectionally produce s adenosyl methionine and a methylated, 2methylated, or trimethylated version of a primary amine, secondary amine, amide, selenonium, sulphonium, tellurium or other. 

Tetrahydrofolate trimethylsulphonium methyltransferase causesTrimethylsulfonium and 6s 5678 Tetrahydrofolate to be bidirectionally metabolized to dimethylsulfide and 5 methyltetrahydrofolate.   

S adenosyl methionine synthase uses Methionine, Water and ATP, to produce phosphate, diphosphate and S-Adenosyl Methionine, resulting in a carbocation rearrangement which redistributes the multiplicity of the hydrogen anion multiplicity from the oxonium between the phosphate groups of ATP to instead encompass s adenosyl methionine which results in ionization of the Sulfur to S+.  

MARS1/MARS2 Methionyl  tRNA Methionyl Ligase. Methionine is important because it is a starting factor or primer in synthesis of more than 99.5 percent of gene transcription products. MARS1, for instance, as Methionine tRNA Ligase catalyzes synthesis of AMP, diphosphate, L-methionyl tRNAMet   from ATP, L – methionine and tRNAMet.   MARS1 occurs in the Nucleus of Homo Sapiens and MARS2 occurs in the mitochondria, performing a role in enabling incipient nuances of synthesis of RNA in Ribosomal Molecular Machines. This enzyme might be Methionyl tRNA synthetase. MARS is inhibited by methylene cysteine complexing through N methylene cysteinylation of itaconate to produce methylene cysteine itaconate.  Also, methylene cysteine itaconate represses both MARS and the NLRP3 nonresolution phase signaling pathways. Itaconate also represses the nonresolution phase including repression of NLRP3.  Itaconate also actives NRF2 signaling. 

Using NAD+ as a cofactor, H20 and s adenosyl L methylene cysteine are metabolized by S adenosyl Methylene cysteine Hydrolase (SAH Hydrolase) to adenosine and methylene cysteine.  

Choline kinase alpha is increased when PEMT is repressed to replace the typically 30 percent of phosphatidylcholine synthesis that PEMT produces compared to the about 70 percent of phosphatidylcholine synthesis produced by the CDP Choline pathway.  The CDP choline pathway produces phosphocholine, Citidylylcholine and phosphatidylcholine using ATP and recycle choline which compares to de novo synthesis of choline when PEMT produces phosphatidylcholine. PEMT also preferentially selects newly produce, lightly glycosylated or nonglycosylated phosphatidylethanolamine as substrate, while also preferring phosphatidylcholine substates which exhibit docosahexaenoic acid, arachidonic acid (extended length versions), oleoylate, palmitoylate, and omega-3 fatty acid species. Choline kinase is increased when PEMT is repressed and the CDP choline pathway supplies high energy phosphocholine used to surmount apoptosis, promote instability, diminish plasticity, produce a xenobiotic/toxic/allergic response, supply energy and substrate to proteolysis activity, increase S1P/S1P receptors activation, increase GPCR receptor activations, activate subclinical complements immunological system, directly activate platelets, and activate S!P lyase therapeutic/immunological resistance pathways.

 Phosphocholine supplies phosphate groups to pathology, pathology vectors, microbes and nonresolution phase signaling, presenting why repression of PEMT can be of consideration detrimental effect. 

Choline kinase enable lipolysis of lipid droplets following deprivation of glucose as it is phosphorylated by AMPK to cause movement to lipid droplets, followed by acetylation by KAT5 causing the homodimer to dissociate into a monomer, such that the monomeric Choline Kinase Alpha version 1 becomes a tyrosine protein kinase which phosphorylates proteins PLIN2 and PLIN3 exhibited upon lipid droplets to activate lipolysis.

Choline Kinase Alpha catalyzes choline and ATP metabolism to phosphocholine, ADP and H+.  


Choline Kinase Alpha catalyzes ethanolamine and ATP metabolisms to phosphoethanolamine, ADP and H+. 


Choline Kinase Alpha version 1 catalyzes L tyrosyl [protein] and ATP metabolism into 0 phospho L tyrosyl [protein], ADP and H+. 


The enzymes of the CDP choline and CDP ethanolamine pathway have some catalytic activity that uses substrate and produces products of their correlated enzyme in the other’s pathway. CDP choline pathway activity produces some products of the CDP ethanolamine pathway while the CDP ethanolamine pathway activity also produces some products of the CDP choline pathway.  

S-adenosyl methylene cysteine Hydrolase, SAH, SAHH. NAD+ availability, compared to NADH, potentiates production of methylene cysteine or HCY from S-Adenosyl methylene cysteine or SAH. This enzyme has bidirectional activity. SAH hydrolase prevents S adenosyl methylene cysteine, S adenosyl  Hcy, from repressing methyltransferase which use S adenosyl methionine as a substrate.  This review made a directed effort determine in S adenosyl methylene cysteine Hcy and methylene cysteine Hcy differentially repressed methyltransferases which use adenosyl methionine compared to methylene cysteine was not able to find a distinction. However, this does not indicate that a distinction does not exist, at least from a potency of repression perspective. 

Using NAD+ as a cofactor, H20 and s adenosyl L methylene cysteine are metabolized by S adenosyl Methylene cysteine Hydrolase, SAH Hydrolase, to adenosine and methylene cysteine.  Adenosine is an inhibitor of choline kinase and mitigates increase in the CDP-choline pathway that can occur when PEMT is repressed.  CDP-Choline pathway synthesizes a less specifically resolution phase fatty acid exhibiting phosphatidylcholine compared to PEMT production of highly resolution phase promoting fatty acids. PEMT also produces de novo choline when it produces phosphatidylcholine from phosphatidylethanolamine.  S adenosyl methylene cysteine is presented as being optimally repressed to lower than 0.012 ?M/L, although the literature does specify if such repression should include SAH Hydrolase, INMT, and other post synthesis metabolism pathways, or if this repression should occur before SAH and INMT because SAH hydrolase produces methylene cysteine from S adenosyl methylene cysteine, such that methylene cysteine is presented as being toxic.  Although being repressive of choline kinase, and although repression of choline kinase alpha has the potential of disrupting almost every known pathology affecting homo sapiens, adenosine can then be directed to AMP by adenosine kinase bidirectionally with 5’ Nucleotidase production of Adenosine from AMP.  Adenosine can also be directed to Inosine by Adenosine Deaminase.  

Methylene cysteine can be of D or L chirality while the research observes that biologically activate version of methylene cysteine are of L chirality, although D methylene cysteine can exist in experimental condition and possibly at nominal levels in physiology as levels of methylene cysteine increase.  It has been putatively presents that PEMT production of s adenosyl methylene cysteine is not toxic, while other research does not observe such paradox, while PEMT production of D chirality as an explanation has not even been putatively presented.  PEMT production of s-adenosyl methylene cysteine is interesting because PEMT also produces methionine compared to other methyltransferases which uses adenosyl methionine as substrate, suggesting that PEMT is particularly intended to initiate and sustain biosynthesis by supplying methylene cysteine for BHMT, BHMT2, Methionine Synthases, and Cystathionine Beta Synthase to release sequestration of resources performed by methylene cysteine and to sustain availability of methionine for 99.5 percent or protein encoding and supply methionine for 100 percent of protein synthesis as the first protein which tRNA includes in any protein synthesis. There are numerous methyltransferases and methylpherases which produced S adenosyl methylene cysteine and this include histone methyltransferase which promote methylation of transcription factors and methylation of DNA, constituting important epigenetic modulation of genetic transcription.

Indolethylamine N Methyltransferase catalyzes the bidirectional metabolisms of an amine (primary, secondary or tertiary amine) and S-adenosyl methionine to a methylated tertiary amine, S Adenosyl methylene cysteine and H+. Indolethylamine N Methyltransferase catalyzes the bidirectional metabolisms of dimethylsulfide and S-adenosyl methionine to trimethylsulfonium and S Adenosyl methylene cysteine.  Trimethylsulfonium is a substrate for THMT and Tetrahydrofolate Sulphonium methyltransferase. Dimethyl Sulfide, Trimethylsulfonium, a primary methylated amine, a secondary methylated amine. 2-teinmethylthioethanol, Dimethyl Selenide, Dimethyl Telluride, Diethylsulfide, Tryptamine, Diethylsulfide, all along with H+ are substrates of INMT.  Increased levels of S-Adenosyl Methionine can naturally potentiate this enzyme toward S-Adenosyl Methionine, but the trimethylated versions of these substrates are inclusive in catalyzing activity toward S –Adenosyl Methionine.  Trimethylsulfonium, Trimethylselenonium, Trimethyltellurium , and possibly Trimethylglycine are substrates or products, although Trimethylglycine can be used by BHMT to produce Methionine and Dimethylglycine.  Trimethylsulfonium produces linear graphs of the depletion of S-Adenosyl methylene cysteine or SAH because it is used by TTMT toward 6s 5678 Tetrahydrofolate/Dimethylsulfide, and used toward Thioglycolic Acid/Methionine by THMT Thetin methylene cysteine methylpherase.

Cystathionine beta synthase is activated by S-adenosyl methionine and by methylene cysteine, Hcy as substrate, although methylene cysteine is regarded as an inhibitor of Cystathionine Beta Synthase.  Cystathionine beta synthase canonical function is present as pyridoxal 5’ phosphate reliant metabolisms of L methylene cysteine and L serine to Water, and L,L cystathionine. The cystathionine enzymes of the transsulfuration pathway are known to potentially have multiple alternate catalysis.   Pyridoxal 5’ Phosphate is the catalytic cofactor version of Vitamin B6 which can be known as pyridoxine.  Cystathionine beta synthase is increased in both early gestation before emergence of structure supplying nutrition of from the gestational host to the emerging gestational development complex emerges and is increased in disease such as oncology. Cystathionine beta synthase can be imported into the mitochondria by HSP70 during Hypoxia or activation of the Hypoxia Response Element regardless of if there is an actual exhibition of hypoxia.  Cystathionine beta synthase is canonically presented as catalyzing metabolism of L methylene cysteine and L serine to H2O, L,L cystathionine, using also pyridoxal 5’ phosphate as a cofactor.  This review is finding that most enzymes can have multiple other pathways, substrates and products. 

Cystathionine has been suggested to now have more than merely putative exhibition of an attached heme oxygenase which metabolizes Retinol to Retinoic Acid, Retinoic Acid to Retinamide,  Retinamide to thioretinaco, thus enabling the exhibition of thioretinaco ozonide in the cristae of the inner mitochondrial membrane where the electron transport pathway is then resultantly initiated.  The thioretinaco ozonide complex then receives high energy electrons that have been packed into NADH and released as the boundless version of Hydrogen Anion as 2 eV, Fluorescence including quantum multiplicity which can include wave, energy, superposition potentialities but are not quantized enabling their hydrogen anion boundless condition to receive and redistribute in fractals up to about 4 eV at a time. This boundless activity by Hydrogen anion and Helium/hydrogen anion conjugates enable exhibition of celestial entities or stars among the universes and enables distribution or receiving of hydrogen anion boundless influences to physiology, biology, energy production, energy storage, structural polymerization and other activity. Thioretinaco ozonide receiving of high energy electrons allows it to become metabolized to become the ATP synthase complex which is complex 5 of the electron transport pathway, while also being a primary of the mitochondrial permeability transition pore which control production and distribution of ATP and which when dysregulated opens to promote apoptosis and necrosis.  ATP synthase and electron transport pathway complex 5, then performs oxidative phosphorylation in which about 42, 43, or 44 percent of the high energy electrons released as hydrogen anion multiplicity that has not be used to support the electron transport pathway, which uses about 57, 58 or 59 percent of this resource, is then packed into oxygen to produce oxonium that is then also packed between the phosphate groups of ATP.  Cystathionine beta synthase is increased in catalysis above baseline, similarly to cystathionine gamma lyase, by influx of CA2+, while this Ca2+ can also be used by mitochondria to increase ATP synthase because the electron transport pathway typically requires Ca2+. 

Glycolysis's fructose 1,6 bisphosphate becomes 2 becomes 2 molecules of glyceraldehyde 3 phosphate, explaining how each molecule of glucose becomes 2 molecules of pyruvate and 2 molecules of NADH, although ATP is also produced in the second of the major phases of glycolysis, although the Leubering shunt redirects about 19 percent of glycolytic 1,3 bisphosphate to 2,3 BPG which enhances oxygen by complexing it anion character with the three cationic factors in the central oxygen integrating structure of hemoglobin while 2,3 BPG can be metabolized toward 3 glyceraldyde. 

Cystathionine Gamma Lyase follows cystathionine beta synthase in the transsulfuration pathway. Cystathionine beta synthase is not presented in the research and data as being repressed by methylene cysteine. Cystathionine gamma lyase uses cystathionine to produce L cysteine and can use L cysteine and L methylene cysteine as substrate, resulting in synthesis also of H2S and lanthionine. Cystathionine gamma lyase using two molecules of methylene cysteine which are metabolized to H2S and lanthionine or methyllanthionine. 

Human cystathionine gamma lyase exhibits a “profligacy” which includes synthesis of H2S from cysteine and includes synthesis of H2S from methylene cysteine which is clinically known as Hcy. Cystathionine gamma lyase performs a gamma replacement catalysis which condenses two molecules of methylene cysteine to produced H2S and Homolanthionine. Cystathionine gamma lyase exhibits a beta replacement catalysis which condenses two molecules of cysteine to produce lanthionine. The alpha exclusion catalysis of cystathionine gamma lyase, in a specific research article, is presumably the use of L,L cystathionine to produce L cysteine, ammonia, and 2 oxobutanoate at a rate supported by pyridoxal 5’ phosphate availability, although this catalysis is not presented in the research literature as including H2S synthesis. Lanthionine differs from L,L cystathionine by a methylene group. Homolanthionine differs from L,L cystathionine by a methylene group. Alpha and Beta catalysis of cystathionine gamma lyase is linked to about 70 percent of H2S synthesis within typical physiological conditions although increasing methylene cysteine levels can make alpha and gamma catalytic contribution of cystathionine gamma lyase activity increase to nearly 90 percent of H2S production.

Thiopurine/Thioether S Methyltransferase use substrates, Existing S-Adenosyl l methylene cysteine, H+, and 6 methylthiopurine, substrates 6 – methyl thioguanine, H+ and existing S -adenosyl L methylene cysteine, and substrates S -adenosyl L methylene cysteine and a thiopurine s – methylether.  Thiopurine S methyltransferase catalyzes the methylation or attachment of a methyl group to thiopurine pharmacological products including S methylation of 6 mercaptopurine, 6 thioguanine, azathioprine, and others, resulting deactivation of these factors to prevent accumulation and repress toxic effect.  Allopurinol represses TPMT and Azathioprine potentially enhances TPMT availability and activity.  TPMT catalyzes s adenosyl L methionine and a thiopurine metabolism to S-adenosyl L methylene cysteine and a thiopurine S methylether. TPMT catalyzes mercaptopurine and s adenosyl L methionine metabolism to 6 methylthiopurine, S adenosyl L methylene cystine and H+.  6 thioguanine and S adenosyl L methionine are metabolized by TPMT to 6 methylthioguinine, S adenosyl L methylene cysteine and H+. TPMT and BHMT2 are interesting because TPMT has not had a naturally occurring substrate ascertained although it is a naturally occurring enzyme, while BHMT2 has not had a primary physiological substrate ascertained for it although s methylmethionine sulfonium is a primary substrate that is naturally occurring and originates outside of physiology.

Version before most Recent

​​​​

A massive oxygenation event in the earlier development of the Earth caused Oxygen to become among the strong biosynthetic electron withdrawing groups and to be participated in electron withdrawing groups other than cyano molecules which can be toxic. The oxygenic even assists in increase the size of organisms and promoted exhibition of organisms with more than 1 foundational biological compartment.  Oxygen is distributed by mechanisms including circulatory factors to reach the ;mitochondria where Thioretinaco Ozonide complexes in the cristae of the inner mitochondrial membrane initiate the electron transport pathway which involves using 4 complexes to modulate proton and electron movement across membranes to result Thioretinaco Ozonide becoming the ATP synthase complex which produces ATP while also enabling the function of Oxidative phosphorylation which produced 30, 32 or more molecules of ATP from glucose as aerobic glycolysis when P53 is not exhibited while this is reduced to 6, 9 or more molecules of ATP from glucose when P53 is exhibited as Anaerobic glycolysis.   Aerobic glycolysis typically is used to indicate that Pemt is repressed, P53 should be exhibited but is in some way subverted and glycolysis is dysregulated to produce maximal or more energy molecules used in a different way compared to typical levels.  

​​

Hydrogen anion (H2e1p as hydrogen with another high energy electron) is an important factor in enabling and sustaining celestial entities and the extra high energy electron om Hydrogen (H2e1p instead of hydrogen as H1e1p) can be released as eV or fluorescence. Glycolysis captures this energy, forwards it to the Krebs cycle, then the Krebs cycle forwards it to the electron transport pathway, as between 6 and 9, more or less, high energy electron carrier substrate for the electron transport pathway (anaerobic glycolysis or P53 repression of Glut glucose absorption, P53 repression of Insulin receptor, and P53 inhibition Glucose 6 phosphate dehydrogenase enabled entry of glucose into glycolysis/pentosephosphate/hexosemonophosphate pathways) or about between 32 and 38 more or less high energy electrons in carriers available as electron transport pathway substrate (canonical function or anaerobic glycolysis with protection of Pemt function, both of which compare to the pathology syndrome of the same or more level of electron transport pathway substrate when aerobic glycolysis is not protected by Pemt function and when this energy pathway becomes dysregulated in disease known as the pathology syndrome aerobic glycolysis ) of carriers of high energy electrons(NADH/NAD+, FAD/FADH2, other).   

Aerobic glycolysis exhibits conditions that commandeer available glycolysis resources and redirect these away from possible pathways as NADH and Pyruvate redirection to NAD+ and lactate ion because repression of glucose 6 phosphate dehydrogenase by p53 decrease the ability of pathways to produce nucleotides and nadph and Acetyl - CoA.   Parp signaling in Homologous and nonHomologous DNA repair uses NAD+ and is prolonged because of inadequate nucleotides for DNA repair, resulting in a pathway of increasing DNA impairment, increasing strength of gradient NAD+ gradient to strengthen direction of pyruvate and NADH to lactate anion ad NAD+, increasing DNA impairment, causing apoptosis of among already differentiated tissue, causing stemness reserves to enter development while be prevented from completing differentiation while also being prevented from complete escape from stemness, training of an overly resilient phenotype, increasing methylene cysteine from nicotinamide remnants left over from Parp removal of ribose from NAD+ because Parp uses ribose redistribution to produce gradients to recruit ribose exhibiting RNA and recruit ribose exhibiting DNA,  depleting NAD+ which causes Parp to complex with Dbc1 which is a causal indicator of functional and genetic advanced aging, causing P53 to promote its own genetic and protein/protein pathway deterioration, finally producing phenotype of oncology, disease and detrimental aspect of aging phenotype. 

​​

Pi3k is linked with oncology and resistance to oncology because Pi3k inhibits the major oncology suppressor p53, causing Glut receptors to move to the plasma membrane to vastly increase glucose absorption and causing glucose 6 phosphate dehydrogenase to increase entry of glucose into glycolysis, pentose phosphate and hexose monophosphate pathways. P53 repression, also, unrepresses the insulin receptor, and the unrepressed insulin receptor can functionally amplify the activity of the phosphofructokinase activity and interact with lysosomal ragulator complexes to recruit and activate mTorc1 catalytic activity.  This review has found hundreds of molecules, pathways, therapeutics and strategies able to be used now and in the future to abrogate what is known of as disease and aging, while some have been achieved in nonhuman contexts and Homo Sapiens tissue.  Most, if not all,  are directly or indirectly linked to Pemt, Hydrogen Anion, Carriers of Hydrogen Ion, conditions directly linked to these or other. Most, if not all, in some way were galvanized by organizations, groups, systems and institution of civilizations along with patterns exhibited in Human events, philosophical and other contexts, including human outcomes within and outside of civilization's contexts. The key factor is a requirement for integrative program management which is able to focuse these into solutions to be reduced to practice and reduced to solutions for implementation. 

 

The electron transport pathway frees high energy electrons from carriers to supply thioretinaco ozonide complex with resources  in the cristae of the inner mitochondrial membrane to cause it to become complex 5 of the electron transport pathway, then supplies resources also the complex 5 which is ATP synthase which performs oxidative phosphorylation to produce ATP as an easily regulated and control source of energy against natural gradients as a characteristics of life.  This pathway has to be commandeered, redirected, or removed in detrimental aspects of age, disease and for vital being to no longer be exhibited.  High energy electrons also are sequestered by CH2 when CH2 is activated by strong electron withdrawing groups to polymerize the ribose and deoxyribose in production of RNA, DNA, NAD+/NADH, NADP+/NADPH and diverse other molecules.

Hydrogen anion, (H2e1p), in carriers, structure, membranes, and alkaline strong ions promote biology enabling background foundational alkaline disequilibrium. Other alkaline factors in tissues and structure, or monocytes, can also potentially promote a background alkaline influence.  Fatty Acid alkanes are examples of factors also promoting alkalinity in the background.  H+, H+ derivatives and other cations produce acidic or positive polarity compared to the negative polarity of alkaline factors.  The strong ions are a group of alkaline or acidic and positively polarized cationic molecules that are reviewed in medicine, essential care contexts, to determine their cumulative comparative polarity, pH, proton balances, acidity or alkalinity. Specifically, NAD+ and NADPH, along with FAD and FADH2, NADP+ and NADPH and other redox molecule pairings are a synapse in which the ionized molecules such as NAD+ has abdicated, released or had oxidized from its structure the hydrogen anion, compared to NADH which has been reduced by acquisition of either a high energy electron or hydrogen with a high energy electron.  The high energy electrons, when not acquired, are unbounded by quantization exist not in version that has been collapsed into particle version, but as eV, fluorescence, energy, superposition, or quantum characteristics. 

Essentially the eV- potential of the unbound hydrogen anion exists in the NAD+ and NADH synapse as multiplicity or potential multiplicity between being acquisitioned by NAD+ to produce NADH compared to being abdicated by NADH to produce NAD+. 80,000 molecules have NHD domains, nudix homology domains, that are essentially inflated by or functional differently upon acquisition of NAD+ to participate in such Hydrogen anion dynamics or synapse. High energy electrons or high energy electrons encapsulated within molecules to make them safe compared to electrons from artificial light or electrical components which can be detrimental.  Photons, as light quanta, and phonons, as sound or thermal quanta, can be translated into electrons in the photoelectric effect, using melanin, neuromelanin, metals, and crystalline lattisces which vibrate to allow the bosonic character of phonons to produce electron interactions which can translated into energy.  

High energy electrons or Hydrogen anion which exhibits a high energy electron, can be acquired through nutrition, supplements, light or phonons, CH2 acquisition of electrons (to polymerize RNA, DNA, Fatty Acids, Fatty Acid Alkanes, NAD+, NADH+, NADP+, NADPH and numerous other factors), paramagnetic interactions, quantum spin liquid(quantum entangled relationships that potentially interact at up to 30,000 times the velocity of light and reach into already exhibited eras and which reach into future eras, elemental conjugates of Hydrogen anion, high vapor pressure elements such as Sodium and Lithium which sequester Hydrogen anion from the numerous low vapor pressure elements, biosynthetic processes and in other modalities.   

Hydrogen anion is included as at least one of the hydrogens in methyl groups, CH3.  CH3 or a methyl group is included in methionine. Methionine can be produced in number of modalities, including Methionine Synthase complexes CH3 with methylene cysteine to produce methionine, when BHMT uses Betaine (n,n,n glycine Betaine or trimethylglycine) and methylene cysteine to produce methionine, when the enzyme BHMT uses S-methylmethionine sulfonium and methylene cysteine to produce methionine,  when PEMT uses S-adenosyl methylene cysteine and S-adenosyl methionine to produce methionine, other more obscure pathways, and when one of the most abundant enzymes in physiology known as THMT (thetin - methylene cysteine methylpherase) uses a number of substrates (2 methylthetin, trimethylsulfonium, and others) to produce methylthioglycolic acid and methionine.         

THMT is interesting because it is among the most abundant enzymes in physiology and because of inadequate sulfur availability. THMT has intramolecular sulfide linkages which complex with sulfide from outside of the molecular structure.  Sulfur inadequacy causes these intramolecular sulfide linkages to complete themselves instead of using extramolecular sulfide, resulting in the THMT entering a gelatinous inactivated phase in tissue where it is exhibited. THMT is a major vector of depleting methylene cysteine depletion, although THMT produces both L-methionine and S-methylthioglycolic acid.   s-methylthionglycolic acid exhibits glycolic acid which, in the early 1900s, became regarded as either the center or a center of medicinal chemistry because it naturally derivatizes conditions and molecules to more environment specific metabolites and substrates.  This process potentiates derivation of specific therapeutic interventional and supportive molecules in vivo and in vitro.   Thioglycolic acid was used beginning in the 1880s when a 1878, 1870 and 1882 series of research studies found that it was produced THMT using a synthetic metabolite (2 methylthetin) to deplete Methylene cysteine.  Physiologically, Methylthioglycolic acid is important because it exhibits a methyl group, sulfur which is natural sequestering factor for hydrogen anion in physiology and in the biome, and work to support glycolic acid capacity of derivatizing interventional molecules while also supporting the role of glycolic acid as a desquamation vector like other alpha hydroxy acid. Methyl groups and sulfur also resolve a number of dysbiosis in biosynthetic, metabolic, structural, hormonal and other pathways. 

S-adenosyl methionine synthase, then, is able to complex ATP with methionine to produce S-adenosylmethionine.  The ATP complex exhibits Hydrogen anions multiplicity packed into the oxonium exhibited between the Phosphate Groups of ATP.  The literatures observes that 2 eV- is freed from each molecule of NADH that has H oxidized from it, although both FADH2 and NADH are used by the Electron transport pathway's 4 complexes.  The electron transport pathway also uses FADH2 and other factors as substrate to obtain and transfer Hydrogen anion's multiplicity. Thioretinaco Ozonide is also supplied with high energy electrons causing it to become metabolized into becoming complex 5 of the electron transport pathway, also known as the ATP Synthase complex.  The ATP Synthase complex then use Oxygen, Ozone, and high energy electrons to perform what is known of as Oxidative Phosphorylation, essentially translating the about 42, 43, or 44 percent of the original 2 eV- derived from Hydrogen anion oxidation (release) from NADH by packing these fractal amounts of hydrogen anion multiplicity into the oxonium that is exhibited between the phosphate groups of ATP, ADP and in AMP.  

S-adenosyl methionine synthase complexes ATP with methionine to produce S-adenosylmethionine, such that the complexing of these factors activates a carbocation rearrangement, known as Hydrogen anion shift, (H2e1p)'ic' shift or methyl shift.   The hydrogen anion multiplicity of ATP is redistributed about the complete S-Adenosylmethionine structure, resulting in ionization of the Sulfur of the methionine structure and turning S-adenosyl methionine into a "enzyme."  Pemt removes the CH3 and potentially removes a hydrogen anion multiplicity fractal, then attaches this CH3, its hydrogen anion multiplicity fractal and its lone pair of electrons to one of the three open locations of the lead ethanolamine group of newly produced, lightly glycosylated or unglycosylated phosphatidylethanolamine.  The first of three sequential CH3 transfers by PEMT enzyme produces PMME, then the second produces PDME and the third produces brand new, de novo, choline as the lead group of newly synthesized phosphatidylcholine. This newly produced phosphatidylcholine selectively exhibits fatty acids DHA, Arachidonic Acid, Palmitoyl fatty acid, oleoyl fatty acid and Omega-3, which resolution phase and resolution eicosanoid potentiators.  

Derived from nutrition, the CDP-ethanolamine pathway, phosphatidylserine decarboxylase 1 in the mitochondrial inner membrane, phosphatidylserine decarboxylase 2 in the Golgi/Vacuolar complex, and possibly in other pathways, phosphatidylserine participates with PMME, PDME, enhanced fatty acid phosphatidylcholine with newly synthesized choline and methylthioglycolic acid to causes abiotic/biotic phase separation, sequestration of biological useful factors for import into the biological phase, desquamation of squamous tissue factors, removal of aberrant polymerizations including methylene cysteine polymerizations which can be a foundational factor in disease, structural deterioration of oncology causing molecules, promotes production of tissue plasminogen activator's super clot busting activity, production of serine protease to proteolyze proteins to foundational levels for plasticity levels mimicking gestational plasticity, and enables expression of oxytocin which is a foundational molecule in human social, emotional, group, individual, population level, civilization level and species level connections and prioritization.   

CH2 or methylene is in a biologically activated status, although not necessarily activated by strong electron withdrawing groups, such that CH2 exhibited in methylene cysteine (clinically known as Hcy) is in structurally deactivated status in which Sulfur in methylene cysteine acquires the ability of CH2 to sequester electrons.  The sulfur in methylene cysteine, thus, is able to sequester electrons and participate in redox transactions to acquire electrons and acquire hydrogen anion multiplicity which causes protonating of tissue, monocytes, enzymes, structure and other factors to become protonated, essentially exhibiting hydrogen anion with the high energy electron removed to remove the specific use of hydrogen anion in the biological context and essentially potentially exhibiting hydrogen without an electron which is canonically a "proton" comprised of Nucleus, 1 proton and no electron. Methylene Cysteine is different from typical cysteine in this regard, changing the function of cysteine in structure.  Cystathionine beta synthase metabolism of methylene cysteine to cystathionine and H2S followed by cystathionine gamma lyase production cysteine and H2S from cystathionine care only some of these enzyme's catalytic activities. Cystathionine Beta Synthase is inhibited by methylene cysteine, while cystathionine gamma lyase is not inhibited by methylene cysteine, is inhibited by decreased cystathionine, inhibits itself by its own production of H2S, and helps cystathionine beta synthase escape repression by methylene cysteine by increasing cystathionine beta synthase access to H2S.  Cystathionine beta synthase requires use of s-adenosyl methionine to become activated.  

Cystathionine beta synthase is increased in expression by either noncanonical HRE response element HIF signaling and or canonical HRE HIF response signaling in specific conditions including gestation to prevent detrimental apoptosis before the gestational nutritional supply complex emerges and separately in oncology.  Pemt2 L which emerges along with Pemt3 L at conclusion of gestation to regulate Pemt1 S which emerges relevantly to conception, presents a correlation because Pemt2 L, Pemt3 L both are "obliterated in function" in correlation to advancement of oncology and other disease, although the dissociation of the only known habitat for Pemt2 L and Pemt3 L known as the mitochondrial associated membrane participates in repressing the function of PEMT2 L and Pemt3 L.  Pemt1 S can also be inhibited in oncology and disease.  However, when Pemt2 S, Pemt3 S and Pemt1 S are all activate, the gradient for competition for the supply of S-adenosyl methionine to Pemt can be improved to compete with other methyltransferase including DNA methyltransferase and methyltransferase otherwise which are primary toxic factor intervention pathways for hormones, xenobiotics, metals, other toxins, and particularly being used by nicotinamide methyltransferase detoxification by methylation for nicotinamide produces produced Parp signaling which removes ribose from NAD+ because the ribose is redistributed to local substrate to produce a gradient upon which Ribose exhibiting DNA and ribose exhibiting RNA can be recruited to the loci of DNA repair.  S-adenosylmethionine synthase competes for ATP with such as pathways phosphorylation cascade and choline kinase which is increased in almost every disease and almost every version of oncology, if not every disease and every version of oncology.  Pemt enzymes then compete with other methyltransferases and other enzymes such as cystathionine beta synthase for available s-adenosyl methionine.  

However, cysteine is a foundation for methylene cysteine which has a methyl group and cysteine with the CH2 of cysteine being structurally deactivated to delegate participation in redox transactions.  Methylene cysteine is known clinically as Hcy, while this review found that methylene cysteine is so toxic, that using the word to often can cause detriment, thus presenting the opportunity to use a more accurate description of methylene cysteine which represents the CH2 exhibited within Cysteine, along with a methyl group.  Also, methylene cysteine is methylated to produce methionine.  Methionine is used as priming sequence in the production of 99 percent or more of proteins.  methionyl-tRNA Synthetase can mistakenly use methylene cysteine instead of methionine in its translation of methionine for methionine encoded tRNA.   Also, the variant MARS1 is known to be linked to oncology.  However, methylene or CH2 is often used therapeutically such as methylene blue and specific types of light.  Concludingly, CH2 methylene is integrated into Cysteine with an active delegation of its redox potential to the Sulfur along with exhibition of a methyl group to comprise methylene cysteine. Methylene cysteine is methylated to produced methionine. ATP is attached to methionine to produce S-adenosyl methionine. and S-adenosylmethionine becomes an enzyme, while S-adenosylmethionine is used by a number of interventional methyltransferase to remove the methyl group and produce methylene cysteine. 

Pemt removes a methyl group from s-adenosylmethionine and uses a molecule of methylene cysteine to produce methionine and another molecule of nontoxic methylene cysteine which is considered to be clinically nontoxic, explaining how different methylene cysteine levels in different physiological instances can have sometimes very disparate health statuses.  Choline requirements per day for Adults can be more than 1000 mg, although between 4 and 7 mg per kg of anatomical mass per day was derived in this review using early developmental status data and more advanced phases of being data.  Maternal choline supplementation became advised resultant of studies which caused choline to be placed among required nutrients in the later 1990s. Breast feeding with choline adequate and folate adequate Human breast milk can cause substantial improvement in development, cognition, health status, cognitive performance, expanse of being and other indicators. Supplemental repression of methylene cysteine has been correlated in the search with reconstitution of vital being in the clinical setting. NADH supplementation and methylene cysteine repression have been experimentally able to complete abolish small nonhuman mammal differences in early developmental and advanced aging including visual, cognitive, mobility, and other differences.  Other factors in extreme homeostatic aging have been linked to repression of mTorc1 signaling and sustainment of mTorc2, including FoxO sustainment of stemness tissue reserves and FoxO sustainment of mTorc2.  mTorc2 sustains the mitochondrial associated membrane which is the habitat for Pemt2 L and Pemt3 L. 

Other studies have already produced at least a 200 percent increase in expanse of being and elimination of diseases exhibited in Human physiology by removing processed and thermodynamically prepared nutritional factors from the nutritional regimen of a small mammalian species. The studies suggests that clinical formulation of required daily nutrients is required regardless of nutritional obtainment if using thermodynamically prepared nutritional factors and because absorption levels of nutrients can be as low as 5 percent.  

However, sustained regulation of the mitochondrial permeability pore through which ATP is exported and other factors are imported has emerged as an important factor in diverse aspects of homeostasis.  The electron transport pathway and complex 5 ATP synthesis, are initiated by the Thioretinaco ozonide complex in the cristae of the inner mitochondrial membrane. Dysbiosis of the mitochondria is integral in sustained disease or sustained impairment. Essentially, the mitochondria is where ATP synthesis occurs and supply of phosphatidylethanolamine for PEMT function, regulated supply of Ca2+ from Endoplasmic Reticulum or other organelles is essential to production of ATP, mitochondrial signaling is important in interactive control of the cytoplasm and foundational biological compartment, proteins from signals outside of the plasma membrane and outside of the mitochondria and from the nucleus all can require entry into the mitochondria to maintain mitochondrial DNA, manage metabolisms, participate in metabolism and determine if and when a foundational biological compartment should continue to exist or should systematically deteriorate. Mitochondria number can change dynamically and can increase requirements for oxygen and other material, while separation of the mitochondria from the endoplasmic reticulum, deterioration of the ability of the mitochondria to import proteins known as MPOS which occurs along with among accumulation of unimported proteins, impaired ability for mitochondrial apoptosis signals to be exported, availability of autophagy and proteolysis to clear such accumulated proteins, and nonresolution phase signaling which occurs to potentiate export of a disease phenotype using ESVs or exocytic vesicles to other tissues and foundational biological compartments, and decreased mitochondrial membrane potentials which cause mitophagy recycling of mitochondria into discrete smaller mitochondria which experience autophagy if membrane potentials are too deteriorated each present or experience complexing with other mitochondria if membrane potentials are adequate, each present information about how important the supply of energy, materials and signaling from mitochondria are to complex organisms.  

A number of specific apoptosis signals from the mitochondria are linked to oncology when being prevented from becoming exported or are not produced because MPOS repression of mitochondrial protein import. A diverse array of antibiotics have emerged to exhibit intricate mechanisms that change biological function, RNA function, DNA function, and change other factors, which is a different perspective from that which is typically communicated to clinicians and communicated in clinical care contexts. Doxycycline, for instance, is known to cause the mitochondrion to attach to the endoplasmic reticulum.  However, doxycycline also promotes impaired exchange of signals between DNA in the mitochondria and DNA i the nucleus, resulting in accumulation of unfolded proteins in the mitochondria which produces the Unfolded Protein Protective Response. The increase in contact points between the mitochondrion and the endoplasmic reticulum produced by doxycycline did not surmount the impairment of protein exchange produced by doxycycline, resulting in protection of some versions of oncology, although the possibility of use in combination therapy for cytotoxic effect may emerge. 

Tfam is a protein imported into the mitochondria from its transcriptional activation in the nucleus, while Tfam exclusion from the mitochondria prevents its ability to participate in maintaining, repairing and transcriptionally activating mitochondrial proteins.  Repression of Tfam activity, like Dbc1/Parp complexes, decreased NAD+, methylene cysteine, s-adenosyl methylene cysteine, AP1, SP1, iNOS/NOS2, methylglyoxal, oxalate, increased insulin signaling, reactive oxygen species, increase in choline kinase, decreased Pemt function, removal the mitochondrial associated membrane, and repression or removal of Pemt2 L and Pemt3 L, all are linked to disease and detrimental aspects of advancing age. 

S-adenosyl methylene cysteine is a product of at least INMT methyltransferase activity which bidirectionally converts S-adenosyl methylene cysteine with s - adenosyl methionine. This can be a rescue pathway for S-adenosyl methionine synthesis to support Pemt and other methyltransferases. S-adenosyl methylene cysteine is metabolized to methylene cysteine by SAH hydrolase (S adenosyl methylene cysteine hydrolase, S adenosyl Hcy Hydrolase, SAH). SAH hydrolase is bidirectional and it can produce adenosine and methylene cysteine from S adenosyl methylene cysteine according to gradients of availability of these factors and according to NAD+ availability in its typical ratio of NAD+/NADH.  SAH hydrolase can also produce S adenosyl methylene cysteine from adenosine and methylene cysteine, correlative gradients of these factors and comparative NADH increase which diminishes the NAD+/NADH ratio. The literature presents that aggregate typical ratio in mammalian tissue can be near, about or at a NAD+/NADH ration of 3/10.  However, within the plasma membrane, the cytoplasm can typically exhibit NAD+/NADH ratio near, about or at 700/1 which favors a gradient toward derivation of NADH which is reasonable because sequestration of the boundless multiplicity of hydrogen anion enables synthesis of NADH and FADH2 used in supply of substrate(pyruvate and NADH) to pathways such as from glycolysis to Krebs cycle toward electron transport pathway and from glycolysis to Lactate Anion and NAD+ toward Parp signaling, supply of substrate from Krebs to the Electron Transport Pathway.  

INMT methyltransferase can produce trimethylation products for amines, amides, sulfur, selenide and other factors, resulting also in trimethylsulfonium which can either use trimethylsulphonium and dimethylsulfide to produce dimethylsulfide and 5-methyltetrahydrofolate, followed 5-methyltetrahydrofolate being directed toward MTHFR and then to methionine synthase production of methionine. Also, trimethylsulphonium can be directed to THMT to use methylene cysteine and trimethylsulphonium to produce methionine and methylthioglycolic acid.

Among the pathways of metabolizing methylene cysteine, cystathionine beta synthase and cystathionine gamma lyase are transsulfuration pathway components which do not recycle methyl cysteine, These components and the transulfuration deteriorate methylene cysteine to Cysteine and H2S, although these components have other catalytic activity.  Cystathionine beta synthase produces H2S and cystathionine in particular, while cystathionine gamma lyase produces cysteine and H2S in particular.

Methionyl-tRNA synthetase is known to mistakenly use methylene cysteine in place of methionine because these molecules differ by a methyl group, which causes Methionyl-tRNA to intervene this condition by producing methylene thiolactone which is toxic, similarly to methylene cysteine'eic'acid as Hcy'eic' acid and methylene cysteine. Each should be prevented and intervened therapeutically.  Cystathionine beta synthase and its structurally attached heme oxygenase can use methylene cysteine thiolactone to produce retinoic acid from retinol, retinamide from retinoic acid, and thioretinamide from retinamide.  Influx of Ca2+ increases cystathionine beta synthase activity above baseline and increases cystathionine gamma lyase activity above baseline. 

The diversity in pathways that decrease methylene cysteine, Hcy, and S-adenosyl methylene cysteine, S-adenosyl Hcy, are important because genetic status, tissue, metabolic conditions and environment can result in expression of different enzymes in different tissue and expression of enzymes at different levels in different tissue.  

Folate, methyltetrahydrofolate and Vitamin B12 methylcobalamin are substrate for methionine synthase.    

Enlyte, EnlyteRx and advanced formulations of EnlyteRx are each foundational therapies of methylene cysteine, Hcy, repression.  Statistically, methylene cysteine, Hcy, should be suppressed to lower than 6 or 7 um/L toward a therapeutic objective of about 3.7 um/L, while S-adenosyl methylene cysteine should be suppressed to be lower than 0.012 um/L.  

Between about to about 9 or molecules of high energy electron carriers, NADH and FADH2, are culminatingly supplied to the electron transport pathway per cycle from Glycolysis, to Krebs cycle, to the electrons transport pathway, during P53 repression of glucose 6 phosphate dehydrogenase linked to anaerobic glycolysis, while some of the literature observes between about 32 and 38 molecules of NADH and FADH2 are culminatingly supply to the electron transport pathway  when P53 is not expressed.  P53 expression produces syndrome or context where P53 pathways and genetic sequencing become increasingly susceptible to impairment or surmounting, resulting in dysregulation of glycolysis, while anytime glycolysis occurs without the protection of Pemt enzyme activity, there is also a likelihood of either dysregulation of potential for dysregulation of glycolysis. The dysregulation of glycolysis involves unhindered glycolysis that can include producing more glycolytic products that is typical per cycle and including potential directing of the glycolytic products toward the multiple pathways of glycolysis potentially including an increasingly focused directing of pyruvate and NADH toward lactate anion, NAD+, Parp signaling and the dysbiosis syndrome parthanatos, although the potential for overproduction of substrate toward the electron transport pathway does not seem to be presented strongly in the research and literature. 

NAD+ is essential to Glucose 6 Phosphate Dehydrogenase enablement of glucose to enter glycolysis which becomes available for glycolysis, pentose phosphate and hexose monophosphate pathways.  There are a number of pathways which obtain substrate from glycolysis including pyruvate dehydrogenase directing of NADH and Pyruvate toward lactate anion and NAD+ which can be used by Parp signaling at loci of DNA repair.  Parp removes ribose from NAD+ and produces Nicotinamide remnants which can be salvaged into NAD+/NADH cycling, can repress or obscure the Sirt1 NHD Nudix homology domain to cause Sirt1 to abdicate its deacetylase activity for a number of other catalytic activities, or can become detoxified using nicotinamide methyltransferase which causes increased levels of methylene cysteine.  

Thus within the cytoplasm, a near, about or at 700/1 ration of NAD+/NADH is presented in the research literature, while near, about or at 3/10 ratio of NAD+/NADH is presented as occurring in mammalian tissues, occurring as a synapse in which these factors can attach to the Nudix Homology Domains, NHD, of 80,000 or more carriers of NAD+/NADH synaptic components in biology. NAD+ and NADH or paralleled by NADP+/NADPH which are linked to different activity, sometimes considered to be NAD linkage to catabolic activity to derive biologically factors while NADP is liked to anabolic activity.  Other carriers of hydrogen anion can exhibit correlation with particular pathways and kinds of activity also. The ratio of NADP+/NADPH is presented as being 0.005.   

About 40 percent or as much as 70 percent of NAD+ is found in the mitochondria, according to the literature. NAD+ is produced, recycled and regenerated by metabolic and circadian pathways, which can involve use of the Earths fields and possibly light from celestial entities as pathways including in producing, recycling and sequestration of hydrogen anion multiplicity into NAD+ or other carriers of hydrogen anion. NaAM, NR, NMN, Niacin, Niacinamide, and nicotinic acid potentiate NAD and NAD potentiates NADP. 

This review found information that confirms that hydrogen anion in the boundless condition can donate, and even receive to reconstitute, its multiplicity in fractal levels.  This confirms that it exists in the boundless condition as a field and exists in the reduced to particle version (electron) as a disjoint field with other hydrogen anion in the universes and in possibly in the universe of universes. These suggest an aether exists that is captured and sequestered by physiology and interacted with to the universes level which occurs at up to 30,000 times the velocity of light, resulting in an interactive systems of systems that allows humans to interact with material of the universe and expanse of the universe before factors exhibit characteristics that Humans can observe. 

Clearly, this potentiates that human activity, cognition, perception, creativity, expression, admiration, exploration, sense of wonder, constructive activity, captured representation of and understanding of the universes, extend to the most incipient instances of creative forces and creative nuance, while also changes or bends the universes into multiplicities. Some such multiplicities such as particle functions and release from superposition seem completely unnecessary except to support Human observation, cognition and the support of the conditions essential for life, particularly intelligent life.  Certainly, life, intelligent life, interactively extends to the creatively incipient aspects of the universe, while understanding, appreciation, acknowledgement of that creative influence and fulfillment of the potential that the favor of such incipient creative nuance has potentiated, continues to bend the universes to the benefit of humanity and to the benefit of the Human experience. Every scientific and philosophical context exhibit nuance of the uncertainty principle where some aspects of everything cannot be completely explained or represented in canonical models. This uncertainty is more than likely to be the result of modalities in which the Universes are changed interactively by Life, particularly intelligent life.  This review looked for confirmation of these context in material aspects of activity and found that in instances before massive levels of EMF emerged to compete with physiological Human interactivity with the Universes and found that in instances of events with massive detrimental effect to vital being there was also a correlated increase massive displacement of stability among the universes celestial entities.  

 

Humans were intended to be here, were intended to live their lives and were intended to exhibit vital being indefinitely, thus bringing the otherwise inanimate aspects of the universe, too, to life. The universes, too, for every Human has some aspect the uniquely interacts with them.  Abated being would not cause such a universes level tumult if it were not displacing outcomes and factors in the future which were intended and if it were not displacing factors that have emerged in other eras, if it were not affective to Human consideration, and if the most incipient of human inclination and activity were not preventative of its detrimental potential. 

The synapse between redox paired molecules that carry or potentially carry Hydrogen anion exhibits a polarity that can be used by molecules, acquired by molecules, become translate into biologically enabling and sustaining factors or characteristics, and can contribute to fields and potentials used to maintain a pH near, about or at pH 7.4 used in essential medicine care contexts as an indicator of awareness, cognitive function, vital function and physiological stability. 

​​

Environmental, aquatic, atmospheric and other toxins, hydrocarbons, dioxins, polycyclic aromatic and other particular or impaired physiology potentiate decreased percentage composition of oxygen in the atmosphere or physiology which cause activation HRE response element which can be mistakenly activated by toxins even if oxygen levels are not diminished which cause the HRE and other response elements to be activated including SRE Serum Response elements, while also apoptosis of foundational biological compartments are also repressed to prevent physiological impairment in low oxygen conditions.     This can disrupt Thioretinaco Ozonide Function and potentiate pathology linked to proliferation of tissue.  

Thioretinaco Ozonide becomes the ATP complex, although Thioretinaco can also be displaced by EMF, Ionizing Radiation, methylene cysteine, oncology causing toxins, dental plaque, vascular plaque, brain plaque, potentially plaque of Islets which repress Insulin synthesis, microbial proteins, viral proteins, and disease.    

​​

Oxidative disease is that which maintains Thioretinaco Ozonide function and ATP synthesis at ATP Synthase while glycolytic disease involves either repression of Thioretinaco Ozonide and glycolytic production of energy or a massive increase glycolytic energy production along with activate Thioretinaco Ozonide.   

​​

High energy levels improve resilience and cause apoptosis to be avoided.  HRE response can be involved in repressing apoptosis,  Inhibition of the enzyme Pemt production of resolution phase fatty acid dense de novo choline as phosphatidylcholine causes increased levels of the CDP-Choline pathway which does produce such new resolution phase fatty acid dense de novo choline as phosphatidylcholine.  The CDP-Choline pathway produces phosphocholine, S1P, S1P receptor activation, GPCR receptor activation, and diverse other factors that provide high energy high resistance and highly resilient repression of apoptosis.    Phosphorylation cascades also supply cytokines with energy and resources to activate diverse pathways potentiating numerous outcomes including high energy repression of apoptosis and nonresolution phase signaling linked to pathology.   Immunological signaling can involve such phosphorylation cascade.    

 

The CDP-Choline pathway attaches ATP to choline, while ATP is used by massive phosphorylation cascade activity.  Displacement of Thioretinaco Ozonide and disruption of ATP synthase can be replaced by deregulated glycolysis which produces massive amounts of energy for phosphorylation cascades.  

​​

Another modality of response to toxins, xenobiotics, allergy potentiating factors are methyltransferases which attach CH3 methyl groups to the factors to deactivate and metabolize such factors.     Methyltransferases compete with the enzyme Pemt for methyl groups and for substrate S-Adenosylmethionine. 

Pi3k/Akt/mTorc1 signaling causes growth in response to mTorc1 reading of Ragulation complexes at the lysosome which arrange themselves or reading according sensing of growth factors, carbohydrate, nutrients, amino acids or Oleoyl phosphatidic Acid 18/3 species, resulting in use of energy resources including ATP.    Pi3k/Akt signaling is linked with resistant disease and represses P53 to promote disease, dysregulated growth and other factors. 

​​

Glycolysis and its production of energy from glucose including NADH and pyruvate, which can be repressed by P53 as anaerobic glycolysis or becomes dysregulated as disease promoting aerobic glycolysis when Pemt is represses and when P53 is surmounted, impaired or circumvented.   Glycolysis can be commandeered particularly when P53 is exhibited because P53 decrease glucose entry into pentose phosphate, hexose monophosphate and glycolysis pathways, resulting in massive decrease in Acetyl-CoA, massive decrease in NADPH, massive decrease in pyruvate and massive decrease in nucleotide synthesis. Resultantly, Parp signaling at loci of DNA impairment, DNA repair and DNA replication increases awaiting deficient nucleotides to arrive as Parp removes the ribose from NAD+ and attaches the ribose to local substrate to enable ribose gradients that recruit Deoxyribonucleic DNA, recruit Ribonucleic Acid RNA and await other material to repair DNA.  Parp signaling prevents optimal DNA repair, causes ribosylation of hemoglobin and increases Hb1ac levels, causes nicotinamide increases which prevent Sirt1 deacetylase activity, causes increased methylene cysteine resultant of methyltransferase detoxificaiton of nicotinamide, causes competition with Pemt for S-Adenosylmethionine, represses Pemt with methylene cysteine, and produces a strong gradient of NAD+ because DNA repair can occur in 1 million or more instances in each foundational biological compartment each day, and causes much of the available pyruvate and NADH in glycolysis to be directed toward lactate and NAD+ to satisfy Parp signaling.  These are aspects of parthanatos.    

 

This presents how Glycolysis can be commandeered and dysregulated to produce resources that are directed toward pathology conditions and presents how phosphorylation and ATP redirection along with commandeering of glycolytic potential can independently causes deterioration of the electron transport pathway, deterioration of the supply of ATP to S-adenosylmethionine synthesis and deterioration of S-adenosylmethionine availability for Pemt, along with causing repression of Pemt. 

The redirection of energy and ATP away from S-adenosylmethionine synthase production of S-Adenosyl methionine, and redirection of S-Adenosylmethionine away from usage by Pemt2 L and Pemt3 L, but possibly expanding to Pemt1 L, are the causing of detrimental aspects of aging and are foundational factors in pervasive if not all disease.   

Pemt2 L and Pemt3 L emerge near conclusion of gestation to regulate the growth potential of Pemt1 S which occurs in the endoplasmic reticulum and which is active at conception.  Pemt2 L and Pemt3 L have their only known habitat as the shared membrane between the mitochondria and the endoplasmic reticulum known as the mitochondrial associated membrane.   mTorc2 signaling promotes association of the Mitochondria and Endoplasmic Reticulum and performs along with some other factors in linking the Mitochondria and Endoplasmic reticulum to enable transport of phosphatidylethanolamine, phosphatidylserine, Ca2+ used in ATP synthesis and other factors.   

​​

Rapamycin is known extend expanse of being because it represses mTorc1 while allowing mTorc2 to function.  Also, the gompertz makeham sigmoidal graph presents risk for abated being by age and has nearly perfectively correlated shape and correlation to typical methylene cysteine by age.  Methylene cysteine, clinically Hcy, is a primary inhibitor of Pemt enzyme function. While redirection of ATP, increase in choline kinase alpha, increase nonresolution phase using ATP, and deterioration of thioretinaco ozonide function, ATP synthase Complex 5 function, Oxygen availability, and commandeer of  Glycolysis supply to Krebs cycle and commandeering of Krebs cycle supply of high energy electrons encapsulated in NADH and FADH2, present perspective of detrimental aging and disease at the foundational biological compartment level.  The factors causing repression of Pemt, mitochondrial production and ATP synthesis are largely known, at least in particular linear metabolic pathways, such that preventing and alleviating these diminished conditions are strongly possible.

Pemt transfer of CH3 from S-adenosyl methionine to in three sequential catalytic actions for complexing with three open locations in the energy levels and orbitals of the ethanolamine lead group of phosphatidylethanolamine in the foundational biological compartment membranes to regulate such growth factors which activate mTorc1 such as Vegf, TGF, and others.  Essentially, CH3, in the homeostatic  condition, can be exhibited on at least a 1 to 1 basis with growth factors in foundational biological compartment membranes while attaching themselves also to the leading edges of expanding structural lattices to prevent unregulated growth.  Functional Pemt can increase the duration between mitotic cycles by between 200 and 300 percent, which, if one considers the Hayflick Limit is about between 200 or 300 percent increase in expanse of being, although the Hayflick limit has found to be inaccurate and to be too low an estimate of potential for expanse of being.

​​

CH3 also promotes a foundational biological alkaline disequilibrium near, and this participates in a redox factor synapses (NAD+/NADH, NADP+/NADPH, FAD/FADH2, others) which releases the boundless status of the high energy electron within the hydrogen anion or releases the hydrogen anion into its boundless condition.  Hydrogen anion is among the three hydrogens of CH3.  The resultant synapse is comprised of released 2eV-, fluorescence, energy, nonquantized, wave function potential, particle function potential, superposition multiplicity. The synapse promotes a background pH near, about or at pH 7.4, supported by similar alkaline factors carriers of hydrogen anion in tissue, structure, enzymes fatty acids, fatty acid alkanes, and circulatory monocytes, and which compares to H+ derivatives in the foreground which produce a gradient upon which biology enable potentials are foundationally derived while also produce a gradient from which energy is derived to enable biological activity to occur against gradients as fundamental self-determination characteristics of life.  Pemt2 L and Pemt3 L are linked to mTorc2 function, association of mitochondria with the endoplasmic reticulum and supply of phospholipids, nutrients and Ca2+ to mitochondria to support electron transport pathway and Thioretinaco Ozonide performance in the ATP synthase  complex. 

There are potentials, opportunities and capabilities derived or able to be derived which prevent, alleviates and intervenes each of the detrimental potentialities in these regard.  individuals, groups, populations, organizations, systems and civilizations must only galvanize themselves in focused achievement thereof, regardless of the social, political and other inertia that has for so long repssed advancements that now seem to have lagged since the 1700s and 1800s, or earlier.  The incipient impetus for Humanity to exhibit their being among one another is the systematic observation, consideration, resolution, alleviation and prevention of disparate outcomes and achievement of comprehensive assuring of Human Welfare, Social Welfare and other nuances of Human Welfare including access to care, quality of being and sustained nuances of vital being. 

​​​

(H2e1p)- the energy that supplies Celestial entities or Stars with high energy molecules to use in catalytic function, release of energy and light production, is integrated into membranes using modalities that include Pemt, along with Pemt de novo synthesis of choline as phosphatidylcholine, and focused exhibition of resolution phase fatty acids in such phosphatidylcholine including Docosahexaenoic Acid, extended length Arachidonic Acid, Oleoyl fatty acid, Palmitoyl first fatty acid in fatty acid beta oxidation pathway, and Omega-3 fatty acids.


Methylene cysteine is methionine with a removed methyl group and methylene cysteine is is toxic, sequesters electrons from tissues, sequesters electrons from carriers of (H2e1p) which is a version of hydrogen with an extra electron used at Universes level for energy, sequesters electrons from enzymes, structure and material otherwise, which can deteriorate the ability of CH3 packed into membranes as methyl groups from promoting a background pH near, about or at pH 7.4.   There are numerous factors that transport, carry and exhibit (H2e1p) version of hydrogen, including CH3 which has at least 1 (H2e1p), including Choline which has 3 molecules of CH3, including phosphatidylcholine which exhibits resolution phase fatty acids an 3 CH3 methyl groups, and other factors, while CH3 is typically exhibited on at least a 1 to 1 basis with growth factors in membranes and attach themselves to the leading edge of expanding or growing lattices in membranes to discontinue growth.   

Cystathionine beta synthesis catabolizes methylene cysteine and produces cysteine and H2S while H2S produces resilience to apoptosis, such that cystathionine beta synthase is increased in early gestation before development of a structure to supply nutrients from the maternal host to the emerging gestational complex emerges, and is also increased in oncology.  HRE hypoxia response element and its activation of numerous response elements that can occur in the same genetic locus such as the SRE serum response element, also represses apoptosis promotes enhance resilience in stem/pluripotent tissues which can be in areas deep in epithelium which are not primary recipients of circulatory system nutrients.  P53, expressed when Pemt is repressed, represses absorption of Glucose and represses entry of glucose into glycolysis, pentose phosphate pathway and hexose monophosphate pathway which causes a syndrome known as parthanatos involving rapid DNA polymorphism, apoptosis among already differentiated tissue, rapid emergence of pluripotent tissue into development, repression of complete removal of stemness and repression of completion of differentiation which programs physiology toward disease.  mTorc1 promotes a senescence phenotype that is toxic and exports disease while P53 promotes senescence, and Ap-1 promotes replicative senescence by repressing telomerase expression which causes chromosome fusion when telomeres become depleted. 

Telomeres are depleted or removed every time a foundational biological compartment experience mitosis during DNA replication, such that when telomeres are depleted chromosomes fuse and mitosis cannot occur. This depletion of telomeres known as the Hayflick limit was once regarded as a limit to age, until it was found that telomerase and Alt replenish telomeres and a major cause of telomere depletion was a choline deficiency and inhibition of the enzyme Pemt. 

Ap1 is interesting because, like parthanatos, it is a training context for highly resilient, highly adaptive, resistance potentiating diseased and oncology exhibiting tissues.   Sp-1, which has extra copies exhibited in G quadruplexes typically within telomere regions, increases Telomerase activity to protect its extra copy habitat while Sp-1 represses CD4+, represses CD8+, increase Pd1 and increase PdL1, all of which deteriorate the adaptive immunological protein presentation, training, monitoring, and response, resulting in obscuring of diseased foundational biological compartments to allow these develop, differentiation, and proliferate into latent disease vectors, oncology and other pathology.   Essentially, Sp-1 becomes an escape mechanisms for highly trained, highly adaptive, high pathology and pathology exporting foundational biological compartments. 

A study by a physician found that two separate populations of about 10,000 exhibited risk for abated being of 500 over a decade of observation when methylene cysteine was above 6 or 7 µmol/L, while the cohort with an instantaneous diagnostic result of methylene cysteine lower than 6 or 7 µmol/L exhibit only 1 instance of abated being over a decade of observation. 

Another study found that a graph of the Gompertz and Makeham statistical representation of risk for incurring abated being by age  produces a sigmoid that is nearly perfectly correlated to the average typical level of methylene cysteine by age, including high correlation with peculiarities in the graph exhibited beginning with octogenarian status. 

Growth, Energy, high Insulin signaling, Phosphorylation cascade, increase in the CDP-Choline pathway, displacement of Thioretinaco Ozonide, displacement of the ATP synthase Complex, glycolytic dysregulation, repression of Pemt2 L, repression of Pemt3 L, disruption of the mitochondrial association membrane, and then dysregulation of Pemt1 S and deterioration of Pemt1 S,  conclusively have emerge as central factors in pervasive disease and the cause of diminished aspects of aging.   

Glucose enters glycolysis when not prevented by P53 and not prevented by inadequate NAD+.  Glucose products energy factors that can be transported to mitochondria, uses by the foundational biological compartment and become transported to the Krebs Cycle.  The Krebs cycle then synthesizes energy molecules that can be used by the foundational biological compartment and transported to the Electron Transport Pathway.  The electron transport pathway takes energy most as NADH and FADH2 and produces ATP by releasing the electron within the Hydrogen as (H2e1p) or hydrogen with an extra electron.  The electrons, 2 eV-, fluorescent light, and energy are used to produce ATP by packing the energy into the Oxygen as Oxonium between the phosphate groups of ATP, while the electrons are used to reduce 02 which interacts with 2H+ to produce water.   

Repression of Thioretinaco Ozonide, repression of the ATP synthase complex, or both, can occur in a way that causes either Glycolysis or Glycolysis and the Krebs cycle to perform without the ability to produce ATP in the electron transport pathway.  This results in production energy  in a dysregulated modality that is ATP and mostly NADH which compromises the NAD+/NADH ratio, while also being susceptible to dysregulation and commandeering by pathology and pathology vectors. The Electron Transport Pathway typically occurs most stably in mitochondria receiving Ca2+ from endoplasmic reticulum through the mitochondrial associated membrane although mitochondria can receive Ca2+ from other organelles and directly from the cytoplasm. 

The use of Protac to specifically remove and detrimental toxin or enzyme, use CRISPR perfect Genetic Repair to counteract Genetic causalities of Disease, Enzyme replacement to counteract genetic impairment, therapies that decrease methylene cysteine,  Usag-1 repression to cause regeneration of renal tissue, Usag-1 repression to cause regeneration of dental structure, Agrin insertion into cardiac matrix to cause regeneration of the complete cardiac complex, IGF-1 enabled regenerate of Islet production of Insulin, and other emerging capabilities are changing the Human condition, while in order to assure advancement of Humanity, comprehensive assurance of Human, Social, Care, Care Coverage, Housing, Nutrition, Opportunity, Financial, Information and Data aspects of welfare are essential. 

There are therapeutics, pharmacological factors, nutraceuticals, natural factors, foods, surgical and diverse other capabilities able to counter the full stack of disease enabling factors.  It only requires clinician and other resources to determine phenotype of disease and link these to multiple therapies to counteract potential for less than therapeutic effect. 

Original 

PEMT2 emerges at conclusion of gestation to regulated the growth and development which PEMT1 enables at conception. Mitochondria of maternal origin proliferates even before gestation while male contributed mitochondria are either inhibited or deproliferate. Mitochondria attach to numerous intracellular organelles and exchange such as endoplasmic reticulum, nucleus, golgi, cytoskeleton peroxisomes, etc, to obtain Ca2+, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol and other factors, while Ca2+ is used in electron transport pathway to produce ATP, resulting in a closed loop feedback system of atp production and supply of atp from mitochondria to their interaction partners.

Pemt1 is Pemt S, short. Pemt L, for lengthened, is Pemt2 and Pemt3. The membrane shared between the endoplasmic reticulum and mitochondria is knows as the mitochondrial associated membrane. Pemt L as Pemt2 and Pemt3 are better able to traverse the increased depth or complexity, from a membrane perspective, of the mitochondrial associated membrane.

The reason that PemtL and Pemt2 in particular are pervasively diminished in disease, oncology and particularly diminished in advanced phases of conditions, is that these often involve either Impaired ability of mitochondria to import proteins, known as mPOS, or dissociation of the mitochondrial associated membrane which the literature now presents as the central loci of Pemt2 function, or both.

Improved aging involves cellular entities that behave like oncology with unusual resilience to advanced mitotic lineage including genetic, telomeric, apoptosis and mitochondrial resiliency. Oncology and disease involves similar resilience that results in paradoxes in order to achieve such resiliency.

Exhibition of senescence or differentiation to the point that cellular entities do not experience mitosis because of AP1 enabled inability of telomerase to replace telomeres, exhibition of P21, exhibition of P27 or senescent status imposed by tissue level communication such as basolateral/apical polarity.

Extracellular exosomes are used to export and import phenotype, nutrients, enzymes, metabolites, autophagic cargo, and proteins, between cellular entities in lumen or epithelium to promote uniformity. rear / front polarity is used to determine chemotaxis patterns for monocytes used for immunology or stem cellular replenish of tissue specific aggregates of stem cellular entities.

Cellular resilience and deterioration are controlled by diverse programs involving immunological, tissue level, or intracellular signaling, typically cause Bax or Bak factors promotion of apoptosis compared to Bcl2 factors counteracting apoptosis potential signaling. However, mitochondria are used in almost every pathway of programmed apoptosis or cellular level deterioration both in initiation and sustainment of signaling which results in apoptosis.

The ability of Fox proteins which enable and sustain pioneering anatomical development are now known to be result of cellular entities and stem cells to respond to the metabolic characteristics of the environment to exhibit functions of anatomical tissue inherently and aggregate and develop into such anatomical factors in layered phased development process that is less comprised of only very complicated linear development of cellular entities. This new perspective of Fox development increase the potential for pervasive regenerative outcomes including already exhibited ability to regenerate the thymus with only 1 fox protein and the ability to regenerate Islet beta cellular entities with Igf1.

PEMT inhibition results in P53 which inhibits endocytosis of glucose, inhibits entry of glucose into glycolysis, pentose phosphate and hexose monophosphate shunt pathways, causes anaerobic glycolysis, directs available pyruvate to lactate because it produces NAD+ from NADH to sustain parp signaling that can occur about 1 million times in each cellular entity each day, depletes NADH, allows parp to deplete nad+, increase Hb1ac because parp removes the ribose from NAD+ to attach it to material in promotion of a gradient upon which repair material is recruited to loci of DNA repair, and increase methylene cysteine (clinically hcy) because the nicotinamide remnants from nad+ relieved of ribose have to be detoxified by methyltransferase. Dbc1 removes its heterodimer dn from dn Dbc1 to produce Dbc1 which integrates with Sirt1 and displaces nad+ from the Sirt1 NHD nudix homology domain, resulting in Dbc1 interaction with P53 that is essential to P53 being able to convince impaired cellular entities to experience apoptosis through increases in Puma and increase in Bax. Tigar can rescue cellular entities from outcomes impose by P53, although P53 can also promote resilience. Mdm2 causes acetylation of P53 to cause it to rapidly deteriorate, although PTEN protect P53 from Mdm2.

P53 inhibits glycolysis because it is anabolic, risks genetic instability by allowing cellular entities to escape programmed apoptosis, promotes adaptation, promotes resilience, is extremely inefficient in its production of ATP compared to mitochondrial electron transport pathway and compared oxidative phosphorylation. All of these are beneficial during incipient phases of injury or impairment, while, however, promoting disease when exhibited for extended duration and without incipient phase of injury and impairment.

Aerobic glycolysis emerges when PEMT function including PEMT2 is not in place to protect a cellular entity exhibiting impaired, inadequate or nonexisting P53 function.

mPOS or isolation of mitochondria from import of proteins and dissociation of the mitochondrial associated membrane between the mitochondria and the endoplasmic reticulum, each or both results in impaired ability for decisions at the immunological, tissue and cellular level regarding resilience or apoptosis from being affected or imposed. Mitochondria can also experience resilience, and there can be hundreds of mitochondria in a cellular entity while mitochondria can move between cellular entities and exist outside of cellular entity membranes. Mitochondria dissociated from the endoplasmic reticulum or otherwise not involved in organelle exchange of Ca2+ and ATP, can import glycerol, import Ca2+ and import other metabolites directly from the cytosol and cytolplasm while causing impairment of capabilities such as exit of ribosome 80s, 60s and 40s large particles form the nucleus pore. These can cause resilient aging or resilient cellular function in impairment or injury to promote diseases.

Strategies that dissociated, reassociate, enable protein import, disable protein import, reconstitute apoptosis signaling and reconstitute resilience signaling, along with repair of mitochondrial DNA by crispr and along with repair of nucleus DNA by crispr, at some instance, possibly in the near future, are going to abrogate what is known as disease, while even now these factors may be in clinical study and development to abrogate nuances of most disease. Agrin grafts to cardiac extracellular matrix is already known to cause complete regeneration of the cardiac complex. Inhibition of Usag1 and enabling BMP7 expression are already known to cause complete regeneration of dental structures and are known to cause complete regeneration of renal structure and tissue. Inhibition of CD20 is known to stabilize even advanced renal disease. Oncology vaccines are, in some instance, having 100 percent success in producing stable and lasting remission. Populations should be acutely aware of these initiatives, fund these, move these rapidly into practice because these foundationally advance the Human experience.

The paradoxes between extreme stable homeostatic aging have emerged are possible to implement, although practice in these areas are continuing to be developed. Almost in every instance, systems’, information and information systems’ interaction with outcomes and events have caused almost every outcome or event to precise homologues to biology and have caused outcomes and events to elute precise information about the causal factors and potential resolution of pervasive aspects of diminished outcomes. Why and how outcomes occur pervasively present themselves as opportunity review, understand, counteract, prevent, learn and develop ways to improve the Human experience.

The reason that glycolysis is not preferred over oxidative phosphorylation and electron transport pathway include that glycolysis is inefficient at producing ATP from glucose, mitochondrial interaction with organelles and structure is regulated by level of Ca2+ obtained from the interaction partner causing a linking of ATP production directly to the status of the organelle partnered with mitochondria, mitochondria interaction directly with cytosol/cytoplasm derives an expansive resource partner for sterol, glucose, Ca2+, and other factors, potentiating overproduction or dysregulated production of ATP which can cause over activation of ‘ases’ such as ATPase, which can cause subsequent overactivation of phosphate (ADP, ATP, AMP, and linked metabolites, etc) availability for kinase overactivation, these can cause GSK3B activation, g protein coupled receptor activation, S1P receptor activation, and cause enhanced resilience to apoptosis signaling.

Choline kinase is hyperactivated when PEMT is inhibited, this causes the cdp choline pathway to become hyperactivated in production of unenriched diminished DHA/Arachidonate/omega-3 fatty acid phosphatidylcholine along with overproduction of ATP attachment to choline as phosphocholine, and overproduction of S1P. Depletion of S1P by S1P lyase is a major therapeutic and immunological resistance pathway. Hyperproduction of phosphocholine provides substrate for proteolysis that release the ATP for proteolysis and systemic cellular level availability while also producing available of choline for hyperactivation of choline kinase, and while hyperactivation of cdp choline pathway is an allergen, xenobiotic and toxicity response that diminishes plasticity and causes utilization of methyltransferase which compete with Pemt for resources.

Phosphocholine is an allpurpose substrate for pathology and vectors that cause pathology including hyperactivation of resiliency signaling, while also being a subclinical activator of the complements immunological system and while also being able to directly activate platelets.

Inhibition of glycolysis by P53 when Pemt is diminished in availability and function also results decreased acetyl CoA which prevents choline from being stored as acetyl choline by choline acetyltransferase, enhancing the cycle of choline direction toward the cdp choline pathway.

Basolateral apical polarity and rear/front polarity are polarities determined by enzyme expression and location in cellular entities which promote epithelial and lumen tissue stability in the instance of basolateral polarity and which determine chemotaxis patterns with regard to rear/front polarity. Confluence is the ability of cellular entities to inherently sense when they have encountered tissue or structure over a percentage of the cellular surface using ligands that attach the cytoskeleton to external tissue or structure and using cellular/cellular junctions and proteins such as gap junction proteins. Confluence involves P21, P27, and P53 to impose tissue competent growth inhibition and chemotaxis inhibition while Hippo, Yap, Tax, Lat1 and Lat2 are mitotic signals involved confluence most centrally. The factors present in this information typically result in escape from confluence or escape from tissue stability imposed growth and chemotaxis inhibition.  

bottom of page